ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001382.1|Svaricin_1 # 2 # 1003 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.735	BGC0001382.1|Svaricin_1 	2	1003	-	Loose	540	26.1794	OXA-157	31.58	3001462	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCGCAGCTACGGCACCTACGTGGACGGACACGAGCGGCCCTCGGACAAGTGGGTCTACACCGTGCACTCGTCGGCGATGCTGCGGGACACGATGGGCTCGGTCCGGCTCAAACGGGGCCTGGAGCGGGGCCGGATCGCACCGGAGGCCGCCACGGACGACGTGGTCGGCCGGGTGGCGGTCGGCGACGGCCACGACATGGACGCGGCTCTCCACGTCGCCGCGGGTGCGGCCCGGGCCTGGTCGGCGGTTCCGCCGGCCGCCCGGCTGCGGGTGGTGGAGGAGTTCCACCACCTCGTCCGCGAGAAGAGCGCCGAGATCATCGACGTGATGGTCGCCGAGGGCCACCCCCGGATGCTCGCCCGCTGGGAGGTCGCCGGGATGCTGGCGAACACCGGGCCCGAGACCAGGGAGTGGATCGCGGGACAGATGGAGCACCGCCGGCGGCTGGGGCCCCGTGAGCTGACGCTCCGCCGGGTCGCCGACGGGGTCGTGTGCCTCAACCCCCCGCAGAACGCCACGGTCGCCAACGCACTCCTCGGCATCTGGGTCCTCGCGGGCGGCAACTCCCTCGTCGTCCGGGCACCCCGCAGCGCACCGCTCGGCGTGATGCACGCCCTGCACGAACTGATCGTGCCGGCGCTCGAACGGGCCGGCGCACCCCCCGGGGTCCTCTCCGCGATCTGCTCCCCGGCCGGGCCCGCACTGGCCCAGTGGCTGGACAGCCCGCTGGTCGACGACATCATGTACTTCGGGGACAGCGAGAAGGGCATCGCCTTCGGCGCCGAGTGCGTGGCGCGGGGCAAGAAGCCGGTCCTGGAGCTCGCCGGCAACGACATCGTGGTCGTCTGGCGCGACGCGGACCTGGAGCGCGCGGCGGACGCGCTGGCGGAGGCGTTCTACGGCTCCGGGCAGATCTGCATGGTCCCCAACTGCGCCGTGGTGCACCCCGCCGTGGCCGACGAGCTGCTCGGCCTGCTCGCCGACCGGGCGAGGGCGATC	MRSYGTYVDGHERPSDKWVYTVHSSAMLRDTMGSVRLKRGLERGRIAPEAATDDVVGRVAVGDGHDMDAALHVAAGAARAWSAVPPAARLRVVEEFHHLVREKSAEIIDVMVAEGHPRMLARWEVAGMLANTGPETREWIAGQMEHRRRLGPRELTLRRVADGVVCLNPPQNATVANALLGIWVLAGGNSLVVRAPRSAPLGVMHALHELIVPALERAGAPPGVLSAICSPAGPALAQWLDSPLVDDIMYFGDSEKGIAFGAECVARGKKPVLELAGNDIVVVWRDADLERAADALAEAFYGSGQICMVPNCAVVHPAVADELLGLLADRARAI	MMMLSRWRRSAVVLRIAAALLSPLAVAIPAHADAIANAANAVAPKIVERADWGKYFDAEGAKGTIIVLDGRTGGYQAYDSTRANQRMSPASTYKIFNSLLALESGALDNEREIIPWDGKPRSMKRWNAAMNLRDAFRVSCLPCYQVVSRKIARTYAQGKLDAVGYGNHTIGSAADAYWVDNSLQISAREQVVFLQRLARGQLPFSARTQDIVRQISIAEANMDYVLHGKTGWYVDGKHDIGWWVGWIERDGNITTVALNMDMRSDADAPKRARIARAVLKDLKLI	117.19	gnl|BL_ORD_ID|2590|hsp_num:0	3421			528	693	cloxacillin; oxacillin; cefalotin
BGC0001382.1|Svaricin_2 # 1018 # 3855 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.732	BGC0001382.1|Svaricin_2 	1018	3855	-	Loose	750	27.7202	adeF	46.15	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCGAGCTCGCACCCGAGCAGTCCCGGCGAGCCGGCCGGGGCACGCCCGTCGCCGTCGTCGGCATGGCCGGCCGCTTCCCCGGCGCGGACGACGTCGGCCAGTTCTGGCAGAACCTGCTCGACGGCCACGAGTCCGTGCGGGAGTTCACCGCCGACGAGATGCGCGCCGCCGGCGTACCGGAGGCGGGGATCTCCGATCCCAACCGCGTCCCCGCGGGTGCCGACATGGCCGGCGCGGACCTCTTCGACGAGCAGTTCTTCGGCATCACCGGACGTGACGCCGCCCTGATGGACCCGCAGCACCGAATCCTGCTGACCTGCGCCTGGGAGGCGCTCGAGGACGCGGGCACCCGCCCGGACTGGAGCGACGGCCGGATCGGCGTCTTCGCCGCCACGAGCCTGAGCACGTATCTGCTCTCCCAGGTCCTGCGGTCGGCCGACCACGCCGACGAGGCCATGAACTACCCGGTGCTGATCGGGAACGACAAGGACTTCCTCGCCACCCGGGTCGCCTACAAGCTCGGTCTGACCGGCCCGGGCATCAGCGTGGCGACGGCCTGCTCCAGCTCGCTCACCGCCGTGCACCTCGCCTGCACGGCACTGGAACGCGGCGACTGCGACGCTGCCCTCGTCGGCGGCGTCAGCATCACCGTGCCCCAGACCAGCGGCTACCTGTACCAGGAAGGCGGAATCCTCTCCCAGGACGGGCACTGCCGCGTCTTCGACGCCGCGTCCGGCGGCACGGTGAAGGGGAACGGCTGCGGAGTCGTCGTGCTCAAGCCGCTGGACAGGGCACTCGCCGAGGGAGACCGCGTCTACGCGGTGATCCGCGGCAGCGCGGTCAACAACGACGGCTCCGACAAGATCGGTTTCACCGCCCCGGGCCCCGCCGGGCAGCAGGCCGTCATCGAAGCGGCCCTGCGCGACTCCGGCGTGCCGGCGGACTCCATCGGGTACGTCGAGGCGCACGGCACGGGAACCGCGCTCGGCGACCCGCTGGAGCTGCGGGCGCTCGCCGCGGCGCACCGCGCCGCCGGCGGTCCGGCCCCCGACTGCGCCGTCGGCAGCCTCAAGGCCAACATCGGCCATCTCGACGCCGCCGCGGGCGTGGCCGGACTGATCAAGACGGCGCTGGTCCTGCACCACCAGACCGTCCCGCCGCAGATCAACTTCACCGCGCCCAATCCTCACATCGGTCTGGACGCACTCCCCTACCAGGTGCGCACCACTGCCGAGGGCCCTCCCCAACTGCCGCTGCGGGCCGCGGCCGTGAGCTCCTTCGGCCTGGGCGGTACGAACGCGCACTGCGTGCTGGAGGCCGCGCCCCGGCCACAGGACGCGGGGTCCGGGCCGACCGGCGTGCGCTACCCGGTCGTGCTCTCGGGGAAGGACGACCGCGGTCTGCGGGCCGTCGCGCGCCGGCTGCGGGACCACCTCGCGGCCGCGCGGCACCGCCCGACCGTGCGCGACCTCGCGTACACGCTGCTCGCAGGCCGGCAGCCGATGCCCGTGCGGCACGCGTTCGCCGCCGCGGACATCGACGAGGTACTGGCGGAGCTCGACGCGCTCCTGGACGAACGCGAGGACACCCGGGCGGCCGCGGACTCCGGCGTCACCGGGCAGGCCGTGCGGAGCTGGCTGGCCGGGCGGGACCTGCCCGCCGGCGAGTGGGCCGAGGCCTGGGACTTCCGCTCGGCACGCAAAGTCGCCTTGCCGGCCTACCCCTTCCAGCGCAACCGCCACTGGATCGAGGCGGCCCCGCCGACCGGTGGGGCGGTCACGGCCGACGAGTCCGTGGACGCGGGCTCGGGCACGGGAGTGACCAGGGAACAGTTCACCGCCCTGCTCGGGAAGCACCTCGGGGTGACCGGAATCGCCGAGGACGACGACTACTACGACCTCGGCGGGGACTCGATGCTCGCGGTCGAGATCGCCACCTCCCTGCGCGACGCGTTCGGCGTGCCGATCGACCTCGATGTCTTCGCGCAGCTGAGCACGGTGGGCGAACTGGCCGACTACGTCGTGTCCGTCGGCGCGGCCCCGGACGGTGCCCGGGACCGCATCGGGCGCGTCGTGCCGATCCGCCAGGGCGAGGGCCGGACGCTGTTCCTCGTCCACCCCGCGGGGGGCACCAACTTCGTCTACTTCCGGATGGCCGTCCACTCCCGCTCCGCCGAGCCCCTCGCCGCGGTGTCCTACCCCGGTGAGGAGGACGGGCGACCGGGCACGCTGCGGGAGCTGGCGGCGCTCTACGTCGAACAGATCCGGCGCGAGCAGCCCCACGGCCCCTACCGGCTCGGCGGCTACTCCTTCGGCGGCAACGTGCTGTTCGAGATGGCGCTCCAACTGCGGGCTGCGGGCGAGGAGGTCGACACGCTGCTGATGCTGGACAGCCACCCGCCGGAGGCGTACGTCGGCGGCCACATCGGCGACGACGAGTTCGAGCGCGCCGTTCCGCTGCTGCTCACGTCCGCCGCTGCCGACGAGGAGCAGATGGAGCTGCTGCGCCGCGAGGGCTTCGTCGCGGCCTGGCGGCACAACCACGATCTGCTCAAGGGCCACTACCCGGACCGGCGGTTCGACGGCGACATCGTGCTGGTGGTCGCCGAGGAGGACGAGGACGGCGCGCTCCTGGACACCATGCGCATCCGGCGCCTCGACAAGGCGTCCCTCTGGGGCGGTCACGTCGAGGGCCGGGTCGAGGTCCTGAAGACGCCCGGCGACCACTTCAGCATGTTCGAGGACGGCGGGCGGCTCGAAGCGCTCGCCGCGACCTTCGACCGCGCACTGGCACGGATAGCCGAAGCGGCCGGCGGAGACGGGGACCTGGGATGA	MTELAPEQSRRAGRGTPVAVVGMAGRFPGADDVGQFWQNLLDGHESVREFTADEMRAAGVPEAGISDPNRVPAGADMAGADLFDEQFFGITGRDAALMDPQHRILLTCAWEALEDAGTRPDWSDGRIGVFAATSLSTYLLSQVLRSADHADEAMNYPVLIGNDKDFLATRVAYKLGLTGPGISVATACSSSLTAVHLACTALERGDCDAALVGGVSITVPQTSGYLYQEGGILSQDGHCRVFDAASGGTVKGNGCGVVVLKPLDRALAEGDRVYAVIRGSAVNNDGSDKIGFTAPGPAGQQAVIEAALRDSGVPADSIGYVEAHGTGTALGDPLELRALAAAHRAAGGPAPDCAVGSLKANIGHLDAAAGVAGLIKTALVLHHQTVPPQINFTAPNPHIGLDALPYQVRTTAEGPPQLPLRAAAVSSFGLGGTNAHCVLEAAPRPQDAGSGPTGVRYPVVLSGKDDRGLRAVARRLRDHLAAARHRPTVRDLAYTLLAGRQPMPVRHAFAAADIDEVLAELDALLDEREDTRAAADSGVTGQAVRSWLAGRDLPAGEWAEAWDFRSARKVALPAYPFQRNRHWIEAAPPTGGAVTADESVDAGSGTGVTREQFTALLGKHLGVTGIAEDDDYYDLGGDSMLAVEIATSLRDAFGVPIDLDVFAQLSTVGELADYVVSVGAAPDGARDRIGRVVPIRQGEGRTLFLVHPAGGTNFVYFRMAVHSRSAEPLAAVSYPGEEDGRPGTLRELAALYVEQIRREQPHGPYRLGGYSFGGNVLFEMALQLRAAGEEVDTLLMLDSHPPEAYVGGHIGDDEFERAVPLLLTSAAADEEQMELLRREGFVAAWRHNHDLLKGHYPDRRFDGDIVLVVAEEDEDGALLDTMRIRRLDKASLWGGHVEGRVEVLKTPGDHFSMFEDGGRLEALAATFDRALARIAEAAGGDGDLG	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	89.24	gnl|BL_ORD_ID|132|hsp_num:0	153			687	798	tetracycline
BGC0001382.1|Svaricin_3 # 3852 # 7052 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707	BGC0001382.1|Svaricin_3 	3852	7052	-	Loose	1000	140.198	almE	29.17	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAGGGCACACGAAAGCACTTTTGGGGGAAGCATGGGAAGCCAAGAGAGCGTGACGCCGGCGACCCCGGCGCAGCTCAAGCTCTACACACACGCAAGGGTGTTCCCCAGAGACCCGTCGTTCAACCTGGGTGGCACCTTCCACATCACGGGTCCGGTCGACGTCGACCGGCTGAGGACGGTCATCGGGCGGCTGGGGGCGGGAATCCGCGCGCTCAACACCTCATTCGAGGAGCGCGGCGGCACCGTGTACGCAGTCCACCGCGTCCCCGACGTCGCCGACCCGGCCGACCTGGTGACGGTGACCGAACTCCACGGCGAGGGCTTACACGAGGCACCCCGGCGGTTCGCCGCCAAGGCCGACCGCCCCATCCCTCCCGAGGCACCCCGCCAGTACGACTTCGAGATCTTCCGGGCGCCGGACGGAGTGTTCGTCACACTGCTGTTCTCGCACCTGATCTGCGACGCCTACACCTTCTACATGTTCGTCACCGAGCTGGAGCGCCTGTACGCCGACCCGGAGGCCGAACTGACCCCGGCAGCCCTGGACGAGCCCGGCTCGCTCGTCACCGGTGCCGCACCCGCGTCGCCCGCCGCCGTCGACTTCTTCCGCAAGCGGCTCGGTGGGGTGACGACGTTCTCCGACGACCGCCTCCAGGGCAGCCGTGCGGCCGGCGGCGCCCTGCGGGGGCACCAGCGTCACCTCGTCCTCACCGAGGAGGAGAGCGACCGGATCCGTACCAGGGCCGAGGACATCGGTGTCAGTCCCTTCGCCTTCTTCCTCGGGGCGTACCTCCTCGTCCACGCCCGCGTCACCGGCCGGCGCGAGGTCGTCACCGGCCTCCCCCTGGCGAACCGCCGGGGCATCCGCCAGCGCAAGGCGTCCGGATACTTCGTCAACATCCTTCCCCTCGCGGTGGACCTGTCCGGCTACGGCAGCTTCGGCGAGCTGTGCCGGGACGTGCAGGAGACCACGCTCGGAATGCTCCGCTACCAGGGCTTCGACGTGGCCGCCCAGGTCCGGGAGGTGTGCCCCGGTGCCGAGGGCGGCTCCCTCGCGTTCAACAGCGCCTTCACCTACTACAAGCAGCCCCTGCAGATCCGGATCCCGGGCTGCACCATCGAGTCGATCGAACTGCCGCGCCGGTACGCCAAGTACCCCCTCGTCATGAACGTCGAGGACTTCGGTACCAGCTTCAACGTCAACGTCGAGTGCTCCGAGGAGCAGTGGAACACCGACCCGCTCGCCTGCATGCGGCAGGTCCTGGAAACGGTGTCCGCCGCCGGTGCGGACGTGCCCCTGCGCGACATCCCCGCGATGCCCCCGGAGGCGGAGAGGGAGCTGTCCCGGCGCATCAACCCCGGCGCTCGCGTCGTGGACGACGGCCCGTTCCCGTCCCTGACGACGTGGTTCTCGGACGTGGCACGGACCCATGCCGAGCGCGTCGCCGTGCGCGACGGCGACGAGTCCGTCACCTACGCCGAACTGGACGCCCGTGCCGACCGGGTGGCCCACGCCCTCGGCCGCGAGGTACCGGGCGAACACGTCGGTGTGGCCATGCGGCGCGGGTCCGACCTGCTCGCCGTGATCCTCGGTGTGCTCAAGGCGGGCAAGGCGTACGTGCCGCTCGACCCGGGATCGCCCGCGAGCCGTGTCGGCCGGATCCTGGAGAGCTTCCCCGGCGGTCTCCCCGTCGTCGCCGACGAGGAGCGCTGGCCGGACGGGGCGGTGCGCCACCTCGACGCCGCGGCTCTGCTCGTGCCCGGGGAACCGGTTCCCGCACCGGAGCCGGTGAAGGACCCGGACGCCTGCGCGTACACCATCTTCACCTCCGGCTCGACCGGGCGCCCCAAGGGTGTCCAGGTCACGCACAGGAACGTCGTCCGCCTCTTCCGGGCCTGCGAGGAGCACTTCGACTTCGGTCCCGACGACGTCTGGAGCCTGTTCCACTCCTACGCGTTCGACTTCTCGGTCTGGGAGATCTTCGGCGCCCTGCTGTACGGCGGCCAGGTGGCCGTGGTGCCGGCGGACACGGCCCGTTCACCCCAGCAGTTCCGCGACTTCCTCGCCGAGTACGGCGTGACCGTGCTCAACCAGACCCCCTCCGCCTTCGGCCAGCTGCTGAAGGTGCTGCGGCCGGGCGACCGGACCGCACTCGACGTCCGGTACGTCGTCTTCGGCGGCGAGCCCCTCCGCTACGCCGCCCTGCGCCCCTGGTACGAGCTGATGGGCGAGCAGGCACGGCTGGTCAACATGTACGGGATCACCGAGACCACCGTGCACGTCACCCACCACGCGGTCACTCCCGCGGACGCCCTCATGGAGAAGTCCTCGCTGATCGGCAGGCCCCTGGCCGATCTCACCGTCAGCGTCGTCGACGGCGAGGGCCGGCACTGCCCGCCCGGCGTACCCGGAGAACTCGTCGTGTCCGGGCCGGGTGTGACGCTCGGCTACCTCGGCAGGCCCGACCTGACGTCCGAGCGCTTCGTCGTCGCGGACGGAGTCACGGCGTACCGCAGCGGCGATCTCGGTCTGGCCCGGCCGGACGGATCTCTCGTGCACCTGGGCCGCATCGACACCCAGGTCCAGTTGCGCGGCTTCCGCATCGAGCTCGGTGAGGTCGAGTCGGCGCTGCTGTCCGTCGACGGCGTGCGCGAAGCCGCGGTCCGGCTCGACGACCGCGACCCGGAGCATCCGTCCCTCGTCGCCTTCGTCGTGGACTCGGCTGCGGTGCCGGACGACCGGACCCTGCTGCGGCTGCTGCGCGAACGGCTCCCCGCGTACATGGTTCCCGCCAGGACGGTGCGGCTGACGGCCCTGCCGCTGACCGTGAACGGCAAGGTCGACGACTCCGCGCTGCCCTGGCCCTCCCTCGGCGACGCCGTACCGGCCCCCCTCGAGCGCACGCCGACCGGTCGCACCACCACCGACCTGGTGCTCTCCGTGTGGAGTGACGTCCTGCCCGGCGTGAGCGTGGGCGAGGACGACAACTTCTTCGACATCGGAGGCTCCTCGATGCACGTGGCCGACGTGCACACGAGGCTCCAGGAACAACTCCCGGGAGTTCCCCTCGACATGATCGCCCTGTTCACGCACACCACGGTGCGCAGACTGGCCGCGCACATCGACACCCTCGGAGCGGACGGGAAAGCCCCCGGTGCCGCCGGCTCCCCCGCTGCCCAGGAAGGGGCGACCCAGTGA	MRAHESTFGGSMGSQESVTPATPAQLKLYTHARVFPRDPSFNLGGTFHITGPVDVDRLRTVIGRLGAGIRALNTSFEERGGTVYAVHRVPDVADPADLVTVTELHGEGLHEAPRRFAAKADRPIPPEAPRQYDFEIFRAPDGVFVTLLFSHLICDAYTFYMFVTELERLYADPEAELTPAALDEPGSLVTGAAPASPAAVDFFRKRLGGVTTFSDDRLQGSRAAGGALRGHQRHLVLTEEESDRIRTRAEDIGVSPFAFFLGAYLLVHARVTGRREVVTGLPLANRRGIRQRKASGYFVNILPLAVDLSGYGSFGELCRDVQETTLGMLRYQGFDVAAQVREVCPGAEGGSLAFNSAFTYYKQPLQIRIPGCTIESIELPRRYAKYPLVMNVEDFGTSFNVNVECSEEQWNTDPLACMRQVLETVSAAGADVPLRDIPAMPPEAERELSRRINPGARVVDDGPFPSLTTWFSDVARTHAERVAVRDGDESVTYAELDARADRVAHALGREVPGEHVGVAMRRGSDLLAVILGVLKAGKAYVPLDPGSPASRVGRILESFPGGLPVVADEERWPDGAVRHLDAAALLVPGEPVPAPEPVKDPDACAYTIFTSGSTGRPKGVQVTHRNVVRLFRACEEHFDFGPDDVWSLFHSYAFDFSVWEIFGALLYGGQVAVVPADTARSPQQFRDFLAEYGVTVLNQTPSAFGQLLKVLRPGDRTALDVRYVVFGGEPLRYAALRPWYELMGEQARLVNMYGITETTVHVTHHAVTPADALMEKSSLIGRPLADLTVSVVDGEGRHCPPGVPGELVVSGPGVTLGYLGRPDLTSERFVVADGVTAYRSGDLGLARPDGSLVHLGRIDTQVQLRGFRIELGEVESALLSVDGVREAAVRLDDRDPEHPSLVAFVVDSAAVPDDRTLLRLLRERLPAYMVPARTVRLTALPLTVNGKVDDSALPWPSLGDAVPAPLERTPTGRTTTDLVLSVWSDVLPGVSVGEDDNFFDIGGSSMHVADVHTRLQEQLPGVPLDMIALFTHTTVRRLAAHIDTLGADGKAPGAAGSPAAQEGATQ	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	191.73	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1629	colistin A; colistin B
BGC0001382.1|Svaricin_4 # 7049 # 7831 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.727	BGC0001382.1|Svaricin_4 	7049	7831	-	Loose	800	25.409	adeI	44.44	3000780	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCACCGCACTCATCACCGGAGCAACCGCCGGGCTCGGCCGCGCCTTCGCCCAGGCCCTCGCCCGCGACGGATACGGCCTGGTCCTGGTCGCCCGGTCCGAACCCGCGCTCAGGAAGACGGCCGAAGAGCTGCGGGACGCCCACGGCACGGCGGCCGAGGTGCTCGCGGCCGACCTCGCCACCGACGAGGGCTGCGACGCGGTCCGTGCCCGCCTCGTCTCCGGGCCGCGGGTGGATCTGCTCGTCAACAACGCGGGCATCGGACACGAACGCCCCTTCCTGACGAACGGCACCGCCTCGGAAGAACGACTCCTCGACCTCAACGTAAGGGCCGTGCTGCGCCTCACCGACGCGGCACTGACCGCCATGACCGACCGCCGCGGGGGCGCGATCCTCAACGTCGCCAGCGTCGCCGGCGTCGGGCCGTCGTGGCTGAGCTCCACCTATCCGGCGAGCAAGGCGTGGGTGATCGCCTTCACCGAGTCCCTGGCGTGGTCCCGCCAGGTGCGCGAGGCCGGCGTCCGCATGACCGCGGTCCTCCCCGGATACACCCGCACCGAGTTCCACCAGCGCGCCGGCATCCCGACGACGTTCCCGCCGGCCTGGCTGTGGCTGGACGCCGACGACGTGGTGCGCACCGCGCTCCGTGACCTGCACAGGGGAAAGGTCATCAGCGTGCCCAGCCTTCGCTACAAGGCCGCCGCCTGGATGCTGCGGCACCTGCCGCGATCGCTGACGCGCCAGGGCGCCTGGGACATCAGCGCCCATCCGCACCGATGA	MPTALITGATAGLGRAFAQALARDGYGLVLVARSEPALRKTAEELRDAHGTAAEVLAADLATDEGCDAVRARLVSGPRVDLLVNNAGIGHERPFLTNGTASEERLLDLNVRAVLRLTDAALTAMTDRRGGAILNVASVAGVGPSWLSSTYPASKAWVIAFTESLAWSRQVREAGVRMTAVLPGYTRTEFHQRAGIPTTFPPAWLWLDADDVVRTALRDLHRGKVISVPSLRYKAAAWMLRHLPRSLTRQGAWDISAHPHR	MMSAKLWAPALTACALATSIALVGCSKGSDEKQQAAAAQKMPPAEVGVIVAQPQSVEQSVELSGRTSAYQISEVRPQTSGVILKRLFAEGSYVREGQALYELDSRTNRATLENAKASLLQQQANLASLRTKLNRYKQLVSSNAVSKQEYDDLLGQVNVAEAQVAAAKAQVTNANVDLGYSTIRSPISGQSGRSSVTAGALVTANQTDPLVTIQQLDPIYVDINQSSAELLRLRQQLSKGSLNNSNNTKVKLKLEDGSTYPIEGQLAFSDASVNQDTGTITLRAVFSNPNHLLLPGMYTTAQIVQGVVPNAYLIPQAAITRLPTGQAVAMLVNAKGVVESRPVETSGVQGQNWIVTNGLKAGDKVIVDGVAKVKEGQEVSAKPYQAQPANSQGAAPNAAKPAQSGKPQAEQKAASNA	62.50	gnl|BL_ORD_ID|1347|hsp_num:0	1471			957	1038	tetracycline; rifampin; imipenem; trimethoprim; chloramphenicol; ticarcillin
BGC0001382.1|Svaricin_5 # 7861 # 9048 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.705	BGC0001382.1|Svaricin_5 	7861	9048	-	Loose	400	29.6462	Pseudomonas aeruginosa CpxR	28.99	3004054	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGGCGTCATTGAAAAGTGCTATTCCTACACCCGTTCCCGGGAAGGGAAAGCAAGCGGCTACTACCCCTTCTTTGTCAGTTTCGACGGCCGCACCGACGGGGTGGCGCGGCTCTCCGACGGCCGCGAACTCGTGATGTGCGGCTCCAACGACTATCTGGGACTGAGCACCGATCCCCGCGTGACGGGTGCCGCGGCCGAGGCCGCACGCGACCTCGGCGCCGGATGCACGGGGTCCCGCCTGCTCAACGGCAACCTCGAACTGCACGAACGACTGGAGCGCGAGCTCGCCGCCTTCTTCGGCAAGGAGGCGGCCCTGGTCCTCACCACCGGGTACCAGGCCAACCTGGGTGCCGTCGCGGGGCTGTGCGGTCCCGGGGACACCGTGTTCGTCGACCGGGACGCCCACGCCTCGCTCATCGACGCGGTCCGGCTCAGCCGTGCCAGGCTGCAGTGGTTCGACCACAACGACACGGCCGACCTGGCGGCGAAGCTGGCCCGGCATCCGGGCCGCGGCGGCCGACTCGTCGCCGTCGACGGCGTCTACAGCATGGAGGGCGACCTCTGCCCGCTGCCCGAACTGGTGCGGGTCTGCGAGGAGTCCGACGCCACGCTGCTCGTCGACGACGCGCACGGCGCGGGAGTCCTCAGCGCCGGCCGCGGCACCTGCGACCACTTCGGCCTGACCGACAGGGTGCCCCTCATCACCCTGACCTTCTCGAAGGCCTTCGGCTCCATCGGCGGAGCGGTCCTCGGTGACGAGGCCGTCATCGAGTACCTCCGTCACCACGCCCGCAGCCTGCTCTTCTCCGCCAGCAGCAGTCCGGCCAACACCGCTGCGGCGCTGGCGGCGCTCGACATCGTCCGTGACGAGCCCTGGCGCTGCGAGACCGTGGTGAAGAAGGCGGACTACATGCGGCGGGAACTGGCCGCGCTCGGCTACCGCACGGGCAACTCCGAGTCCCCCGTCGTCCCCGTCGACACCCACGACGAACTGCACACCGTCGTCGGGTGGAAGCGCCTGATGGAGGAGGGTGTGTACGTCAACGCCGTCCTGCCACCCGCCGCGTCGCCCCGGCTGCGGACCAGCTACACCGCCGTCCAGACCGACGAGCACCTCGAGCGGACGCTCGCCGCCTTCGCGACCGTGCGGAGCGACCTCGGCCCCGTGCTGACAGACGCCGCGTGA	MGVIEKCYSYTRSREGKASGYYPFFVSFDGRTDGVARLSDGRELVMCGSNDYLGLSTDPRVTGAAAEAARDLGAGCTGSRLLNGNLELHERLERELAAFFGKEAALVLTTGYQANLGAVAGLCGPGDTVFVDRDAHASLIDAVRLSRARLQWFDHNDTADLAAKLARHPGRGGRLVAVDGVYSMEGDLCPLPELVRVCEESDATLLVDDAHGAGVLSAGRGTCDHFGLTDRVPLITLTFSKAFGSIGGAVLGDEAVIEYLRHHARSLLFSASSSPANTAAALAALDIVRDEPWRCETVVKKADYMRRELAALGYRTGNSESPVVPVDTHDELHTVVGWKRLMEEGVYVNAVLPPAASPRLRTSYTAVQTDEHLERTLAAFATVRSDLGPVLTDAA	MSELLLIDDDRELCELLGTWLVQEGFSVRASHDGAQARRALAEQTPDAVVLDVMLPDGSGLELLKQLRGDHPDLPVLMLSARGEPLDRILGLELGADDYLAKPCDPRELTARLRAVLRRTHPAQPSAQMQLGDLSLNLTRGVAQIDGQEISLTLSESRILEALLRQPGEPLDKQALAQLALGRKLTLYDRSLDMHVSNLRKKLGSHPDGSPRILALRGRGYYYSH	175.56	gnl|BL_ORD_ID|2300|hsp_num:0	2685			279	654	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; panipenem; trimethoprim-sulfamethoxazole
BGC0001382.1|Svaricin_6 # 9078 # 9341 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=11bp;gc_cont=0.629	BGC0001382.1|Svaricin_6 	9078	9341	+	Loose	500	23.483	OXA-12	34.48	3001407	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGCGGTACGGAAATCTTCACCGGCGATTTCTATTTCCGAGCAGCCTCGAGCCGGCAATCGGCCGGCAGGCACACACGGCACCGCGTACCTGAAGACGGCGGCGTCCGGTGAGAAAGAGAAGAAGAAAGTAAGATTGCTCAGGCGCGTGAGCGCGCCAAGGCGATGGCCTCGTGCATGTGTACTCCCCCGTACGTTTGCAGACCGGCACTGGCTGGGCACGGACCGAGCCCCAGGCCTGTCAGCAGCAGAGTCCCCCTGGTGA	MAVRKSSPAISISEQPRAGNRPAGTHGTAYLKTAASGEKEKKKVRLLRRVSAPRRWPRACVLPRTFADRHWLGTDRAPGLSAAESPW	MSRLLLSGLLATGLLCAVPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALMGYDSGFLVNEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQYVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYTANILKVSEVEGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKPGKQFASIKAKEEVLAALPAQLKKL	32.95	gnl|BL_ORD_ID|169|hsp_num:0	186			264	351	cloxacillin; oxacillin; cefalotin
BGC0001382.1|Svaricin_7 # 9712 # 10419 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=11bp;gc_cont=0.727	BGC0001382.1|Svaricin_7 	9712	10419	+	Loose	450	46.9802	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	24.62	3004045	protein variant model	F203L	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGTCCGGACGCACCGCCCTCGTCAGCGGGGGGAACCGGGGGATCGGTCTCGCCGTGGCCCGGGCACTGCACGCCGGCGGCGACTCGGTCGCCGTCACCTGCCGGAGCTCCCCACCGCCCGACGACTTCCTGGCGGTCAAGTGCGACGTCACCTCGAAGCAGGAGGTGGACGACGCCGTCGGCCAGGTCGAGGAGACGCTCGGCCCCGTCGAGGTGCTGGTGGCCAACGCCGGCATCACCCGCGACGCGCTGCTGGTCGGCATGGGCGAGGACGACTTCCTCGACGTGGTCGACACCAACCTGATGGGTGCCGTGCGCCTGGTCCGCCGCACCCTGCGCGGCATGGTCCGCCGCCGCCACGGCCGCATCGTGCTGATCTCCTCCACCTCCGCCCTCTCCGGCTCGTCCGGCCAGACCAACTACGCCGCGGCGAAGGCGGGGATGGTCGGGTTCGCCCGATCCCTGGCCCGCGAACTCGGCCGCCGGGACATCACGGTCAACGTGGTCGCGCCGGGCTGGATCGACACCGACATGACCGCCGCGCTGCCGGAGGAACTGCGCAAGGAGGCCGCCGGGACGGTGCCGCTCGGGCGCTTCGGCACCCCGGAGGACGTCGCCGCCACCGTGCGGTTCCTGACCAGCCGGGAAGCGGGCTACATCACCGGAGCCGTCGTGCCCGTCGACGGCGGAATCGGAATGGGGAACTGA	MSGRTALVSGGNRGIGLAVARALHAGGDSVAVTCRSSPPPDDFLAVKCDVTSKQEVDDAVGQVEETLGPVEVLVANAGITRDALLVGMGEDDFLDVVDTNLMGAVRLVRRTLRGMVRRRHGRIVLISSTSALSGSSGQTNYAAAKAGMVGFARSLARELGRRDITVNVVAPGWIDTDMTAALPEELRKEAAGTVPLGRFGTPEDVAATVRFLTSREAGYITGAVVPVDGGIGMGN	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	89.69	gnl|BL_ORD_ID|4712|hsp_num:0	2666			9	759	triclosan
BGC0001382.1|Svaricin_10 # 11800 # 12048 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.639	BGC0001382.1|Svaricin_10 	11800	12048	+	Loose	575	22.3274	MBL1b	38.46	3006951	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MBL beta-lactamase	ATGGCACTCGACCTGAACGAGATCCTCACCGGCCTCAGCGAGATCGTGAACGAGGTGACCGGCACCCCGATCGAGGACATCCAGCCCGACAAGTCGTTCGTCGACGAGCTGGACGTGGACTCGCTGTCCATGGTGGAGGTCATCGTCTCCGCCGAGGAGCGCTTCGACATCCGCATCCCGGAGGAGGAGGCCAAGACCTTCAAGACCGTCCGGGACGCGGCCGACTTCATCCTGCTGCACGCAGGCTGA	MALDLNEILTGLSEIVNEVTGTPIEDIQPDKSFVDELDVDSLSMVEVIVSAEERFDIRIPEEEAKTFKTVRDAADFILLHAG	MKRLILAAAASLLALASAAHADDMPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGHVVLHGGPNAETGKLVERNITALGFQLADLKILINTHAHYDHAGGLAQLKADTGAKLWISRDDAPAMAAGHHIGDNIYGPTPMPAAKPDRSFGDQTKLKLGEIAMVAHLTPGHTIGCTSWTTAVVEKGRPLTVTFPCSLSVAGNVLVGNKTHRTIVADYRASFAKLRAIPTDVMLPAHEEQGNLLAKRQKQLRGDPNAFVDPGELARFVDASEAAFNKELARQQAAGPKP	28.37	gnl|BL_ORD_ID|3692|hsp_num:0	4762			417	495	
BGC0001382.1|Svaricin_13 # 13337 # 14776 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.700	BGC0001382.1|Svaricin_13 	13337	14776	+	Loose	1000	55.0694	almE	24.66	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACGTCAAAGCTATTCACTCCGCATTCGGAAACGACCTACGACGAAGTCGAACGCCAGGCGCTCGGCCTGGCGGAGGCGCTGCGGGCGCGTGGCATCGAAGCCGGTGACCGCGTCACTCTCAAGGCGGGCAATTCGGGCGGTTTCGTCGTCGTCCTCCTCGCCCTGATGCACACCGGGGTCTCGATCGTGCTCCTCGACGACCTCCAGCAGGACGCCGTCACCGAGCGGGTCGTGACCCTGGCCCGCTCCCGGCTGACCATCACCGACGGCACGAACCGGCCACCGGCCGGTGCGACGGTCTCCGTGGACGAGCTCCTCGCCGAGGCGGCCGGCGGCCCCTCCACCACGAGCCATGAGGCGGGGGAGCTCTCCTTCACCGCCTGGCGCGCGCTCCCGGACGGCCTCATCACCTGGTCCTCGGGGTCGACGGGCGAGCCCAAGGGCATCGTCAAGTCCGGCGAGGCCATGCTCCGGAACCTCGACCGCTCCATCGAGCGGATGGGGCACCGCCCGGACGACGTGCTCCTGCCGCTGCTCCCCTTCTCCCACCAGTACGGACTGTCCATGCTGCTCACCGCGTGGCTGGCCCGCTCCTCCCTGGTCGTCGCACCGTACCGGCGGCTGGACCACGCGGTGCGCATGGCAGGCATGTTTGGTGCCACCGTGGTCGACGCCACTCCGGCGGTGCACCTCAGCATCCTCAACCTCGCGGAACGTCGGCCCGAGATGGCGGCGGACCTGCGCAAGGTGCGGATGTACTGCACGGGCGGCGCCCCGCTCGACCGATCCGCGGCCGAACGGTTCGTCGCCGCCTTCGGCCTGCCGCTGCTCGACGGCTACGGCAGCACCGAACTGGGGAACATCGCCTTCGCCACTCCGGACAACCCGGTGGGCTGCGGTCCCGTACTCCCCGGCATCGACGTGCGGCTGGAGTCCGGCCCCGGCGCGGAGGCCCCCGGCATCGGGGAGGTGATGGTCCGCACTCCGGACCTCTTCTCCGGCTATCTGGGCGCGGACGGGCAGGTGGACCCGGTCTCCGGCGACTGGTACCGCACGGGCGACCTGGGGCGCTTCGACGACGAAGGCAACCTGTTCGTCCTCGGCCGCAAGCTCGCCGTCCACCGCATGGGCTACACGCTCTACCCGGAGGTCATCGAGCGCACAGCCGGCGGCTGTGGAGCACCGGTCAAGATCGTCCCGCTGCCCGACGAACGACTCGGCAGCCGGCTGGTGTTCTTCGTCCAGGACCCCGAGGGCCGGGACGTCCTGTACTGGCGCGAGCGCATCTGCGCCCAGCTCTCGCCCTTCGAATACCCCAACCGCGTCGTGGTCTGCGGCGCCTTCCCGCTCAACCGCAACGGAAAGCCGGACAACAAGCAGCTCAGGGCCATGGCACTGGCCGGATCAGAAACACCCGAGGATCGGAGTTCACTCTAG	MTSKLFTPHSETTYDEVERQALGLAEALRARGIEAGDRVTLKAGNSGGFVVVLLALMHTGVSIVLLDDLQQDAVTERVVTLARSRLTITDGTNRPPAGATVSVDELLAEAAGGPSTTSHEAGELSFTAWRALPDGLITWSSGSTGEPKGIVKSGEAMLRNLDRSIERMGHRPDDVLLPLLPFSHQYGLSMLLTAWLARSSLVVAPYRRLDHAVRMAGMFGATVVDATPAVHLSILNLAERRPEMAADLRKVRMYCTGGAPLDRSAAERFVAAFGLPLLDGYGSTELGNIAFATPDNPVGCGPVLPGIDVRLESGPGAEAPGIGEVMVRTPDLFSGYLGADGQVDPVSGDWYRTGDLGRFDDEGNLFVLGRKLAVHRMGYTLYPEVIERTAGGCGAPVKIVPLPDERLGSRLVFFVQDPEGRDVLYWRERICAQLSPFEYPNRVVVCGAFPLNRNGKPDNKQLRAMALAGSETPEDRSSL	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	86.15	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1632	colistin A; colistin B
BGC0001382.1|Svaricin_14 # 14776 # 16053 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.702	BGC0001382.1|Svaricin_14 	14776	16053	+	Loose	800	28.8758	PDC-376	41.07	3005302	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	GTGCGCGCACACGAAACCCGACCGCTCAGGCGGGTGGTCGTCACAGGAACCGGTGTCATCACACCGATCGGCAACACCGTCGAATCGTTCTGGCAGTCCCTGATCGACGGCCGGAGCGGCATCTCCGCCATCGAGTCCTGGGACGCCTCGGACCTGCCGGTCCGTATCGGCGCCGAGGTCAAGGACTTCGACCCCGCGGCCTACATGCCGCACAAGGTGAGCCGCCGCATGGACCCCAGCGCCCAGTACGGGCTGGCGGCCGCCATGGAAGCGGTCCGGGAGGCCAAGCTCGAGATGAGCGACGACCTCGCCGCCCGCACCGGTGTCTATCTGGGCTCGTCCGTGGGCGCCGCCCAGATGACCTACGACACCACGGTCAAGCTCCACGAGCGGGGCGCCCGGGCGGTCAGCCCGTTCTTCTTCGCCACCAGCGGATCGGAGAGCGCCGCGGGCGAGGTCGCCATGTGGCTGGGCGCGCGCGGTCCTTCGTCGAGTCTGAGCACGGCATGCGCCTCCGGGGCGACCTGCATAGGCGAAGCGGCCCGGCTCATCCAGTTCGGGGTGACGGACGTCATGATCGCGGGCGGTGCGGAGGCGCCCGTGACCAGGCTGAACATCGCGGGGGCCGCCGCCTGCCAGGCGCTGTCCCGCCGCAACGACGACCCGTCGCTGGCCTGCCGCCCGTTCGACCGCGAGCGCGACGGCTTCGTCATGGGCGCCGGCGCCGGCGTCGTCGTCCTGGAGGAGTACGAGCACGCGCTGCGCCGCGGTGCGCACATCCTCGGTGAGCTGGCCGGCTACGGCGCCACCACCGACGCGTACCACCTGACCGCCCCCCATCCCGATGCGCTGGGCACCAAGACGGCGATGCGCATCGCGCTCGAGTCGGCGGGCCTGCAGCCGCAGGACGTCGACTACATCAACGCCCACGGCACGAGCACCCAACTCAACGACTCCACCGAGGTGTCCGCCATCCGCGGGGTGTTCGGCGAGCACGCCACGCGCATCCCCGTCAGCTCCACCAAGTCCATGACGGGACACCTCATTTCCGCCACCGGCGCCGTGGAACTCATCGCCGCGCTGCTGGCCGTCCGCCGCGACGTCGTCCCTCCCACCCTCAACTGCAACGACCCGCTGGACCCCGACATCAACTTCGTCCCGGGCGTGGCCCAGGAGTGGGAGGTCGATGTCGCCATGAGCAACTCGTTCGGCTTCGGCGGCCACAACGCCGTCCTCGTAGTGCGCAGCCTCAAGGAGGAAGAGAGTTATGCCGCGTAA	MRAHETRPLRRVVVTGTGVITPIGNTVESFWQSLIDGRSGISAIESWDASDLPVRIGAEVKDFDPAAYMPHKVSRRMDPSAQYGLAAAMEAVREAKLEMSDDLAARTGVYLGSSVGAAQMTYDTTVKLHERGARAVSPFFFATSGSESAAGEVAMWLGARGPSSSLSTACASGATCIGEAARLIQFGVTDVMIAGGAEAPVTRLNIAGAAACQALSRRNDDPSLACRPFDRERDGFVMGAGAGVVVLEEYEHALRRGAHILGELAGYGATTDAYHLTAPHPDALGTKTAMRIALESAGLQPQDVDYINAHGTSTQLNDSTEVSAIRGVFGEHATRIPVSSTKSMTGHLISATGAVELIAALLAVRRDVVPPTLNCNDPLDPDINFVPGVAQEWEVDVAMSNSFGFGGHNAVLVVRSLKEEESYAA	MRDTGFPCLCGIAASTLLFAATSAIAGEAPADRLKTLVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASLHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYTPGSQRLYSNPSIGLFGYLAARSLGQPFERIMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLVKPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGSDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR	107.05	gnl|BL_ORD_ID|3006|hsp_num:0	4034			9	168	
BGC0001382.1|Svaricin_15 # 16043 # 16507 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.714	BGC0001382.1|Svaricin_15 	16043	16507	+	Loose	700	26.1794	ACT-48	26.21	3006243	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGCCGCGTAACGATCTGATGGACACCGCAACGCTTCCGTCCGGGGAGAAGGGCTACGTCGCCCGGCAGGACGTTCCCGCGGGCGCCGTCGTCGGCTCCTGGGAGGAGTCGGCGGTCGACTCCGAGCCCACGAAGTTCACCATCCAGGTCGGCCGCGACCGTCACGTCGACGCCGACGCGGTGCGCTACCTCAACCACTCCTGCGTGCCGAGCACGTTCGTCGACGCCTCGACCGGCAGCGTCGTGGCCCTCCGCCCGCTCGCCGCGGGTGACGCGCTGACGTTCTTCTACCCGTCCACGGAGTGGGAGATGACCACGCCGTTCGACTGCGCCTGCGGCCACGCCGGCTGCCTCGGCAAGATCACCGGCGCCGAGGCGCTCTCCGCTGACGTGCTGCGGCGCTACGCCGTGAACGACCACATCCGCGCCCTGGTCGCCGACCGGGACGCCGTCGCGCTGGGCTGA	MPRNDLMDTATLPSGEKGYVARQDVPAGAVVGSWEESAVDSEPTKFTIQVGRDRHVDADAVRYLNHSCVPSTFVDASTGSVVALRPLAAGDALTFFYPSTEWEMTTPFDCACGHAGCLGKITGAEALSADVLRRYAVNDHIRALVADRDAVALG	MMTKTLCCALLLSTSCSVLAAPLSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAKNKPVTPQTLFELGSISKTFTGVLGGDAVARGEISLGDPVTKYWPALTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDSASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMSYEQAITTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMASWVMVNMKPETLQDTSLRQGITLAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPASEVNPPAPPVKASWVHKTGSTGGFGSYAAFIPEKSLGIVMLANKSYPNPARVEAAYRILDALQ	40.42	gnl|BL_ORD_ID|3101|hsp_num:0	4139			162	465	
BGC0001382.1|Svaricin_17 # 18241 # 19428 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.713	BGC0001382.1|Svaricin_17 	18241	19428	+	Loose	1800	27.335	MexD	27.94	3000801	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGGACAGCAGCCCTACCTGCACGTGACCTGGACCGACGACACGACCGGCGCGACCGGCCACCTGGTGATCGACCGCCTGCTGCGCGGAGCGTCGAGCGGCGGGTTGCGCATGCGGTCCGGTTGCACCCTCGAAGAGGTCGCGGACCTCGCCAGGGCCATGACCCTGAAAGAGGCCCTGGTCTACCGGCCCGAGGACCACTACGCACCCTTCGGAGGTGCCAAGGGCGGTATCGACTTCGATCCGTCGCACCCGGACGCCCCCGCCGTGCTCGAACGGTTCCTGCGGGCCGTCCGGCCCCTCGCCGAGACCTACTGGTCGGTGGGCGAAGACCTCGGCACCCGGCAGGAGGACATCGACCGGGCCTTCGAGCGGATCGGCCTCCGTTCCTGTGTCCACGCCGCGCTGCCGTTCGTCGAGGACGGTGCCGACGCCGGACTGACCCGGATCTCCGACGCGTTCGCCGTGGAGGTGGACGGTCTCGGACTCGGAGACACCGTGGGCGGCTACGGAGTGGCCCAGTCGGTCCTGGCCGTGCTGTCGGAGCACCACGAACTGCCGGGCGAACAGACCGCGGTGGTCCAGGGCTTCGGCTCCATGGGGGGTGCCACCGCGCGCTATCTGGCCCGTGCGGGGATCCGGGTCGTCGCCGTCGTCGACCGGGACGGCGTCGTCCTCGACGAGCGGGGTGTCGACGTGGAGCGGCTGCTGGCCGACCGCAGCCCGGCCGGCCTGGTGAACCGGGAGACCCTGCCGCAGGGGGTCACCCTGCTCCCGGTCGAGGACTGGCTCACGGTCGAGACCGACATTCTCGTCACCGCCGCCGCCTCGTACGCCGTCGACGAAACCAACCACGCCGATGTGCGCTGCCGATATCTGGTCGAGGGGGCGAACGTCTCGGTACTGCCGGGCGCCGAGGCGGCACTCGCGGCGCGCGGCGTCGTCGTCGTGCCCGACTTCGCCGCGAACTTCGCCGCCAACAGCTGGTGGTGGTGGACCCTCTTCGGGGACATCGGCCCGGACGCCGACCAGGCCCTCACCAAGATCGAGAAGACGATGCGGGAGATCACGACCGCGATCTTCCAGCGGGTCAGGGAGACCGGGGCGACCCCGAGGCAGGCCGCGACGGCGATCTCCGAGGAGAATCTGCGTCAGGCCCGGGTCCGCTACGGCGACCTCCCGGCCTGA	MGQQPYLHVTWTDDTTGATGHLVIDRLLRGASSGGLRMRSGCTLEEVADLARAMTLKEALVYRPEDHYAPFGGAKGGIDFDPSHPDAPAVLERFLRAVRPLAETYWSVGEDLGTRQEDIDRAFERIGLRSCVHAALPFVEDGADAGLTRISDAFAVEVDGLGLGDTVGGYGVAQSVLAVLSEHHELPGEQTAVVQGFGSMGGATARYLARAGIRVVAVVDRDGVVLDERGVDVERLLADRSPAGLVNRETLPQGVTLLPVEDWLTVETDILVTAAASYAVDETNHADVRCRYLVEGANVSVLPGAEAALAARGVVVVPDFAANFAANSWWWWTLFGDIGPDADQALTKIEKTMREITTAIFQRVRETGATPRQAATAISEENLRQARVRYGDLPA	MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE	37.87	gnl|BL_ORD_ID|1485|hsp_num:0	1523			1932	2136	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
BGC0001382.1|Svaricin_18 # 19688 # 20320 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.692	BGC0001382.1|Svaricin_18 	19688	20320	-	Loose	400	37.3502	MexL	24.61	3003710	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGACAGAAGCGCACCCTTGGTGTGGTGGTGGATTCCAGTGGAGCCCACCGAAGGGACCTGGACGCCCGTGACCGCGTCCTTGCCACCGCGATGAAGATGCTCGGCGAACACGGCTACTCGAAACTCACCATCGGTGGCGTGGCGGCCGAGGCGGGCGTCGGGAAGGCGACGCTGTACCGGTCGTGGCCCAACAAGGCGGCACTGGTGCTGGACGTGATCCGTGGCGAGCTCCGGGACGTGCCCACGGAGGACCTGGGCGACAGCCGTGCCGAGATGCTGGCGCTGGCGTCGCAGGCGCTCGGCCAGTTCTACGGCTCGGATCGGATCAGGACCGTGCTGCCGGCCCTCGTCGGTGACCTGTCGGAGGATTCCGCGCTGCGCCAGCGGCTGTGGGAGGAGATCGTCGACGCCCGCAAGAAGCAGTCGATGACCGTCATGGAGCGGGCGTTGGGCCGGGGCGACCTGCCTGCCGACACCGACGTCTCGCTCGTTCTCGACATGTGGGCGGGCACGATGCTGTTCCGCGCGCTCTTCTCGGCGGACGCCATGGACGACGAGACCATCGAGCGGTTCGTCGACGCCACCATCGCGTCCCCGCCCCGCACGGGCGGTTCGCAGCCCGTCCGCTGA	MGQKRTLGVVVDSSGAHRRDLDARDRVLATAMKMLGEHGYSKLTIGGVAAEAGVGKATLYRSWPNKAALVLDVIRGELRDVPTEDLGDSRAEMLALASQALGQFYGSDRIRTVLPALVGDLSEDSALRQRLWEEIVDARKKQSMTVMERALGRGDLPADTDVSLVLDMWAGTMLFRALFSADAMDDETIERFVDATIASPPRTGGSQPVR	MSESTSSVGPGRPKDPAKREAILEAAKRLFLCNGYDGSSMEAIASEAGVSKLTVYSHFTDKETLFSEAVKAKCAEQLPALYFQLAEGAPLEKVLLNIARGFHRLINSHEAIALTRLMAAQAGQNPKLSELFFEAGPKQVIDEMERLLEQARRSGKLAFPDARHAAEHFFMLVKGCANYRLLIGCAEPLDEAEGERHVEEVVALFLRAFAAGG	99.06	gnl|BL_ORD_ID|4690|hsp_num:0	2219			39	606	erythromycin; tetracycline; triclosan
BGC0001382.1|Svaricin_19 # 20482 # 22113 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.713	BGC0001382.1|Svaricin_19 	20482	22113	-	Loose	910	327.791	lfrA	42.49	3003967	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGGGAAACACGCGCTGCTGAGCGAACGCCGGAAGTGGGCCACGCTGGCGACCGCCTGCCTCACGATGCTGCTGCTCTCGGTGGACCTGACCGTCCTGCACCTGGCCGTTCCCCGGCTGACCGCGGAGCTGCGGCCGACGTCCACCCAACTGCTGTGGATCGCCGACGTGTACGGCTTCGCGCTCGGCGGGCTGCTCATCACGATGGGCAACGTGGGCGACCGGGTCGGCCGCCGACGACTGCTCCTGGTGGGCACGTTCGGGTTCGGTGCGGCATCCGGGCTGACGGCGTACGCGTGGAACGCGGAACTGCTCATCGTGGCGCGCGCCCTGCTGGGGGTCGCCGGCTCGACGCTCATGCCGTCGACGCTCTCGATCATCCGGAACACGTTCACTGATCCGGTCGAGCGGACCCGGGCGATCGGGATCTGGTCGAGTGTCAGCTCCGCGGGTTTCGCCGTGGGGCCGCTGATCGGCGGTCTGCTGCTCGACCACTTCTGGTGGGGGTCGGTCTTCCTGATCAACATCCCGGTGATGCTGCTCATCTTCGTCGTCGGCTTCTTCGTGCTGCCCGAGTCGAAGAACCCGCGGCCCGGGCGGCTGGACGCCCTCAGTGTGCTGCTCTCGGTGGCCGGCATCGCCGCCGTCATCTACACGATCAAGGACGCCGCGCACGACGGGTTCGCCCAGACGGACGTGGCGGTGGCCTGTGTCGTCGGCGTCGGGGCCCTGGCGCTCTTCGCCTGGCGGCAAGGACGCCTGGAGACTCCCCTGATCGACGTCGCACTGTTCCGGAACCGGGGCTTCAGTGCCTCGGTGGGCGCCACGGTGATGGCCATGTTCGCCCTGGCCGGAGTGGGGTTCGTAGGATCGCAGTACTTCCAGGTGGTGCTGGGCTGGTCACCGCTCCGTTCGGCGGTCGCCCAACTGCCGGGCGTGGCCGGGGCCGTGGCCGGGGCCGTTCTGGCGCCGAAGCTGGCGGCCGCCGCGGGCCGGGCCCGCACGGTCGCGCTGGGACTGACGCTGGTGTCCGTCGGACTGCTGCAGTACCTGTGGCTGTCCACGGAGGTCTCCTACCCTGCGGTCCTCGCGGCGCTGATCGTGACCAGCTCCGGGGTCGCGATGACGTTCACCGTGACCGCCGACAGCGTGTTGGAGTCCGTCCCCAGGGAACGCGCCGGAGCCGCCTCGGCGATCTCCGAGACGGCGTACGAGATGGGTGGCGCCCTGGGCATCGCGGTGCTGGGCAGTGTGCTGAGCCGTGTCTACCGCGACGGCCTGGACATGCCGCCGGGGATCCCCGGGGAACACGGGGCCGTCGTCAGGGAGTCGCTCGCCGGCGCCATGGACGTCGCGGGCCGGCTGACCGCCGATCTCGGCGCGGCGCTGGCGACGACGGCACGTGAGGCGTTCATAGGCGGATTCCACGCGACGGTGGCGGCCTGCTCGGGACTGGCCGCGATCGTGATGGTGACCACATGGATCGCCCTGCGCGGAGCCCCCGCGCAGGGCCCCTCGGAGACCGCCGGCGAGGAGGCCGCTCCCGCGACCCCTCCCGCCCGGTCGTCCGGTGACCCGGACACGCTGGTGCTGGTGGCGGACTCCGCGCAGCGGGCGACCACCGGTCCGTGA	MGKHALLSERRKWATLATACLTMLLLSVDLTVLHLAVPRLTAELRPTSTQLLWIADVYGFALGGLLITMGNVGDRVGRRRLLLVGTFGFGAASGLTAYAWNAELLIVARALLGVAGSTLMPSTLSIIRNTFTDPVERTRAIGIWSSVSSAGFAVGPLIGGLLLDHFWWGSVFLINIPVMLLIFVVGFFVLPESKNPRPGRLDALSVLLSVAGIAAVIYTIKDAAHDGFAQTDVAVACVVGVGALALFAWRQGRLETPLIDVALFRNRGFSASVGATVMAMFALAGVGFVGSQYFQVVLGWSPLRSAVAQLPGVAGAVAGAVLAPKLAAAAGRARTVALGLTLVSVGLLQYLWLSTEVSYPAVLAALIVTSSGVAMTFTVTADSVLESVPRERAGAASAISETAYEMGGALGIAVLGSVLSRVYRDGLDMPPGIPGEHGAVVRESLAGAMDVAGRLTADLGAALATTAREAFIGGFHATVAACSGLAAIVMVTTWIALRGAPAQGPSETAGEEAAPATPPARSSGDPDTLVLVADSAQRATTGP	MSTCIEGTPSTTRTPTRAWVALAVLALPVLLIAIDNTVLAFALPLIAEDFRPSATTQLWIVDVYSLVLAALLVAMGSLGDRLGRRRVLLIGGAGFAVVSALAAFAPSTELLVGARALLGVFGAMLMPSTLSLIRNIFTDASARRLAIAIWASCFTAGSALGPIVGGALLEHFHWGAVFLVAVPILLPLLVLGPRLVPESRDPNPGPFDPVSIVLSFTTMLPIVWAVKTAAHDGLSAAAAAAFAVGIVSGALFVRRQNRSATPMLDIGLFKVMPFTSSILANFLSIIGLIGFIFFISQHLQLVLGLSPLTAGLVTLPGAVVSMIAGLAVVKAAKRFAPDTLMVTGLVFVAVGFLMILLFRHNLTVAAIIASFVVLELGVGVSQTVSNDTIVASVPAAKSGAASAVSETAYELGAVVGTATLGTIFTAFYRSNVDVPAGLTPEQTGAAAESIGGAAAVAADLPAATATQLLDSARAAFDSGIAPTAVIAAMLVLAAAAVVGVAFRR	107.74	gnl|BL_ORD_ID|2195|hsp_num:0	2433			54	1449	
BGC0001382.1|Svaricin_20 # 22144 # 25488 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.762	BGC0001382.1|Svaricin_20 	22144	25488	-	Loose	400	28.4906	salD	41.94	3007028	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	ATGCGTTTCGACGTACTGGGCCCCGTGGAGATGAGGAGGGCCGACGGAGCGGCGGTGCCGGTGGGCGGCCCCAGAGTGCGCGGCCTGCTGGCGCTGCTCCTCCTCGGCGCCGGCCAGGTCGTCCGCACGGAGCGCCTGATCGACGGCCTGTACGGCGACCGCCCACCGCGCCACGCGACCCGGGCCCTCCAGTCGCAGGTGTGGCGGCTCCGCCACGCGCTGGACGGCGAAGCGGAGGTGGAGTTCCACCAGTCCGGATACCGGCTCGCCGTGCAACCCGAGTCCGTCGACGCCCATCGTTTCGAACAGCTGGCCGCCGCCGGACGACGGGCGCTGGACTCGGGAGAGTCCGCCCGTGCCACCGAGGCGCTCGACGAAGCGCTCTCGCTCTGGCACGGGGCGGCGCTCTCCGGGGTCGCCGAGACGCCGTTCCTCGCCGCCCAGGCCGCACGCCTGGAGGAACTGCGCTTCACCGCGCTCGAGGACAGGGCGGACGCCGAACTCCTGGCGGGGCGCTGCCGCGGCCTGGTCGCGGAACTGCGCGAGCGCATCTGCGCGGGCCCGCTGCGGGAACGTCCGCGTGGCCAGCTCATGCGCGCGCTCCACGCCTCCGGGCGGACCGCCGAGGCCCTCGCCCTCTACGAGGAGACCCGCCGGGTCCTGGCGGCCGAACTCGGCACGGAACCGGGGGCCGAACTGCGGGCCGTGCACCTCTCGGTCCTGCGCGACGAGCCGGCGGACACACCGCCCCCGGTGGCACTCCGCGCCCGCGGAACCCTGCCACCGCGGAGCGGGCCGGGCCCGGTACCGGCCGCGGCCGGCGCACCGCCGGCCGGGGCCCGGCGGCCCACAGCACCCACCGCACCCACCGCACCCACCGCACCCACCGCGCCGGGTCCTGCCCGGCGGCACCGGCTGCCCGCGCCGCTCACGAGCTTCGTCGGCCGCGACGAGCCGGTCCGGCGCCTCGGCGATCTCCTCGACGAGGTCCGCCTGGTCACGCTCACCGGCCCGGGCGGCTCCGGGAAGACCCGTCTCGCGATCGAGACGGCCACCCGCCGCGAAGGGGACGTGTACCTCGTCGAACTGGCCGGCCAGGCCCCTGCGACCGACGTCCCGCGGGCGGTCCTCGACGCCCTCGGCATCCACGACGCGCCCGTGCTGCCGGTGGCGCCTGCCGGCCGCAGGCGCGGCGGGTCGCCCGTGACCGATCGGCTGGTCTCGGCCCTCGCCGACCGCCGCTCCCTCCTCGTGCTCGACAACTGCGAACACGTCGTCGAGGACGTCAGCCGCCTCGCCCAGGAACTGCTCGACGGCTGTCCCGGCCTCACCGTGCTGGTCACCAGTCGCGAGGCCCTCGGCATCACCGGTGAGACGCTTCTCGCCGTGACGCCCCTGGAGGTGCCGCCGGCCGACGGCGGCACCGACCCGGAGCACGCGCTGCGCTATGCGGCGGTGCGGCTGTTCACCGATCGCGCCCGGGCCGTGCGCTCCGGCTTCGTCCTCGACGCGGAGACCGTCCGGCCGGTGCTGAAGATCTGCCGCGCACTCGACGGTCTTCCGCTCGCCATCGAACTCGCGGCGGCGCGACTGCGCTCACTTCCCCTGGGCGAACTCGCCGCACGGCTCGACGACCGCTTCGCGCTGCTGTCCCGGGGCAGCCGCACGGCGCCGCCGCGGCACCGCACCCTCAGCGCGGTCGTCGACTGGAGCTGGGACCTTCTCGACGAGGAGGAACGCACCCTGGCCCGCCGCCTCTCGGTGTTTCCCGCCGGCGCGACGCAGGCCGCGGCCGAGCGCGTCTGCGGACCGTTCTCCGGCAGCACCCTCGACCTGCTCAGCTCCCTGAGCGACAAGTCGTTCGTCACCGCGACGGGCGAGGCCGAGCCGCGCTTCAGAATGCTGGAGACGGTACGGGCCTACTGCGCGCGGCGGCTGGCCGAGGCCGGGGAGACGGAGTGGATCCGCCGCGCGCACGCCGCGCACGTGACCGAGCTCGCCGAGGCAGCCGCACCCCATCTGCGCGACGCGGCCCAGCTCGACTGGCTCTCCCGGCTGACCGCGGTCCACGACGACATCGTCGCCGCCCTGCACTGGTCCACTCGCGCGGACCCCGCCCGGGCCCTGCGGCTCGCCGCGGCGCTGTGGTCCTACTGGTGGCTGCGCGGCCCGGCCGGTGAGGGCGCCGAGCGGATGCGGGACGTCCTGGTGTCCGCCGGTACCACTCCCCCGCCCGATCTCGCGGCGCAGTACGTCATCTGCGTGGCCGGCACCGTGCTCTCCATGCGACCGACGCCGGATCTGCACTCGCACCTGCGGGCCGCCGTCGCCCTGGGAGACGGCCTGGACACGGCCGGCGCCCATCCGCTGGTCGCCCTGATCCGGCCGGTCGTCGCGCTCGCCACCGGCGACCACGACGCCGAGCTGCCCCCGTTCCCGGACGCGGGACGGGCCGAGCCGAACGCCCCGGACGGGGACCCGGCACTGCGGGCCGCCATGCACCAGCTGCTGGGCATGCTCCACCAGGGACGCGGCCGGCCCGACCGCGCGGAGCGCTGGTTCACCGTGGCGCTCGACGGCTTCCGCGCGTCGGGCGACCGTCTCGGCGCCATCCAGGTCCTGCCCGAACTGGCCCGGATCGCCGGGTGGAACGGTCACCACGAGCGTGCCGTGGCGTTCGTCGACGAGGCTCTCGCCCTGGCGGTCCAGCTCGGTTCCACCACCAACGAGGCCTACCTCCTCGGCCGTCGGGCCGCCGAGCGCCGCAGCGTCGGCGACCTCGCCGGCGCCGAGACCGACAGCGCGGCAGCCGGACGGCTGGCACGCGCCGCGGACGCGCCGGAACTGGTGGCGGCGGCGCAGCATCACGCCGGTGAGACGGCCCGGTTGCGCGGGGACCACGCGAGCGCGCGACGGTTCCTGGAGTCGGCGCTCCGCGGCTGCGGGGGGACCTGGCTGGGCGAGGAGATCCGGGTCAGGACGCTCACCGCCCTCGGCCGGGTCAGCCAGGCAGAGGGAGACCCGGGCGGGGCGCGCGAGCGGCACGGGCGTGCGCTGGACATCGTTCTCGTCGGCTGGGACCTGGCGACCATCGCCGACACGGCCGACGGCCTGGCCGGCGTTCTCGTGGCCGACAGCCCGGTCACGGCGGCCACCGTCCTCGGCGCGAGCACCGCGCTCCGCGGGGTGCGGGCCACGGACCGGGACACGGTGCTCGCCGTCCGGGACGCCCGCCGGCACCTCGGAGCGCGGGCGTTCCGCCAGGCATACGGGGCGGGGTCCGCGCTGACCCGGCAGGAGGGTCTCGCACTGCTCGCGAGGGCGCTGTCAGAGATCCGTGAGTGA	MRFDVLGPVEMRRADGAAVPVGGPRVRGLLALLLLGAGQVVRTERLIDGLYGDRPPRHATRALQSQVWRLRHALDGEAEVEFHQSGYRLAVQPESVDAHRFEQLAAAGRRALDSGESARATEALDEALSLWHGAALSGVAETPFLAAQAARLEELRFTALEDRADAELLAGRCRGLVAELRERICAGPLRERPRGQLMRALHASGRTAEALALYEETRRVLAAELGTEPGAELRAVHLSVLRDEPADTPPPVALRARGTLPPRSGPGPVPAAAGAPPAGARRPTAPTAPTAPTAPTAPGPARRHRLPAPLTSFVGRDEPVRRLGDLLDEVRLVTLTGPGGSGKTRLAIETATRREGDVYLVELAGQAPATDVPRAVLDALGIHDAPVLPVAPAGRRRGGSPVTDRLVSALADRRSLLVLDNCEHVVEDVSRLAQELLDGCPGLTVLVTSREALGITGETLLAVTPLEVPPADGGTDPEHALRYAAVRLFTDRARAVRSGFVLDAETVRPVLKICRALDGLPLAIELAAARLRSLPLGELAARLDDRFALLSRGSRTAPPRHRTLSAVVDWSWDLLDEEERTLARRLSVFPAGATQAAAERVCGPFSGSTLDLLSSLSDKSFVTATGEAEPRFRMLETVRAYCARRLAEAGETEWIRRAHAAHVTELAEAAAPHLRDAAQLDWLSRLTAVHDDIVAALHWSTRADPARALRLAAALWSYWWLRGPAGEGAERMRDVLVSAGTTPPPDLAAQYVICVAGTVLSMRPTPDLHSHLRAAVALGDGLDTAGAHPLVALIRPVVALATGDHDAELPPFPDAGRAEPNAPDGDPALRAAMHQLLGMLHQGRGRPDRAERWFTVALDGFRASGDRLGAIQVLPELARIAGWNGHHERAVAFVDEALALAVQLGSTTNEAYLLGRRAAERRSVGDLAGAETDSAAAGRLARAADAPELVAAAQHHAGETARLRGDHASARRFLESALRGCGGTWLGEEIRVRTLTALGRVSQAEGDPGGARERHGRALDIVLVGWDLATIADTADGLAGVLVADSPVTAATVLGASTALRGVRATDRDTVLAVRDARRHLGARAFRQAYGAGSALTRQEGLALLARALSEIRE	MSFYFTEKPFERFGKTLIEEVNLSVEPGEHIAIVGDNGVGKSTLLNAIYNKYNDSTYLMDQELSKYKNETAINYIMSWYPELLDIKLAMQTDYEKIGDYIELNGYEIEEQIILQAKQLNLEESDLDKQMGQLSGGQQTKVALVRAMISEKNLILLDEPTNHLDKQMIHIVVDYIKQAKQSILYVSHHRGFIDETATHIIEITPQATRKFTGNYSQYKSIIDVERETQKKVYEKKQKEIKALEATVDRVKNWHKTANQSASVRNPLEQKRLSKLAQKAKVKESQINQKLEKIKVQQPKSDDRHFHFENQDALNKKYLMQLYDFSITIDGKNIYQNANFEIKDNENIILTGPNGSGKSLLISIIKQSIIPDEGDIYITPSLKIAYFDQKNDNLNYDSTALTMLLNMEGMERSQAQTILASFGFDNQKINLPISQLSMGEKSRLQFVLLYFSNPHLLILDEPTNYFDIATQDLILQMLKQFAGQVMIVTHDEYLKSQITATHWTIKDKKLMNLTLSEKHSPNMVDDTLKLLDDYKSIDEFGHFETDN	204.78	gnl|BL_ORD_ID|4727|hsp_num:0	5739			1032	1125	lincomycin; virginiamycin M1; tiamulin; retapamulin
BGC0001382.1|Svaricin_21 # 25509 # 25706 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.591	BGC0001382.1|Svaricin_21 	25509	25706	-	Loose	500	26.5646	mphL	32.69	3003072	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGAAACGGGGGAACGCTGCTTTGACGCGAGCTGAAGAGGGCCGTGACGATACCGTCCGGCCCGCCATCGACATGCCCGAGGAGACCTTTCTCCTCGAAATTCCCACCCTTCCCGAGATTCTCGGGACCATCTTCTCCGGAGGACCTCTTGAAGCCATTCGCAATGGTTCGGGAAAACAGACGCCAGCAGTCGGCTGA	MKRGNAALTRAEEGRDDTVRPAIDMPEETFLLEIPTLPEILGTIFSGGPLEAIRNGSGKQTPAVG	MEEIKMNTLKIKQLATKEGLNILEDSIKINESGVDFQVAHAKEQNGDKWILRIPRRPESMRHVLQEKKALEIIKNHAGFQVPDWSIFTEDLIAYKQLSGVPAATIDIEQQGYIWSFNEKNAPSEYHISLGKVLANLHSLPQQEFNNIGIEILTANELRASMEQRMNRVKEQYYVNQKLWDRWQAWLTEDSFWPSHVGVTHGDIHPGHILIDKKNNVTGLIDWTEVGIADVSIDFTSHYLLFGKDGLTKLISSYDNAGGKTWSRMDEHIIELLTTSSITVAEYAQVSGLKEMHEAAVHMLATES	21.45	gnl|BL_ORD_ID|2337|hsp_num:0	1240			90	246	erythromycin; clarithromycin; azithromycin
BGC0001382.1|Svaricin_22 # 25996 # 26472 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.719	BGC0001382.1|Svaricin_22 	25996	26472	+	Loose	1450	23.8682	BahA	50.0	3003984	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic inactivation	Bah amidohydrolase	ATGCAGCGGCTGTGGGAAGTGGAAGAAAGCATTCACGTCAAGGCCGCGGCGGACACGCTCTACGACTCCGTTGCGGACGTCAGGGCGATGGGCAGGTGGAGCCCGGAGTGCCGGAGGGTCTGGCTGCCCCGGCCGCCCGTCCGCCGGGGCAGCGGCTTCGTCGGCTTCAACCGCAAGGGGCCGTGGGTGTGGTTCACCTGGTGCCGCGTCGTGCGTGCCGAGCGGCCCCACGCCTTCACCTTCCGGGTCAGCACCTTCGGCCTGCCGGTCGCCGAGTGGGGCTACCGCTTCACGCCCACCGACGACGGCACCCGGGTCACCGAGCACTGGACCGACCTGCGCACCGGACGCGGGGCCCGGCTCACCGAACTGCTCGGACTGGTGTTCACGGGCACCCGTCCGCGCCTGCGCGCCGCACGCAACCGGGCCGGCATGCGCACCACACTCCACCGACTGAAGCAGGCCGCCGAAGGCTGA	MQRLWEVEESIHVKAAADTLYDSVADVRAMGRWSPECRRVWLPRPPVRRGSGFVGFNRKGPWVWFTWCRVVRAERPHAFTFRVSTFGLPVAEWGYRFTPTDDGTRVTEHWTDLRTGRGARLTELLGLVFTGTRPRLRAARNRAGMRTTLHRLKQAAEG	MEIHKEKEKEKGVTFFRRIMANRKRRGPLSPGWKGASLGLGATGFILILIQANYLLTGHGVGKFIVGTFLFLFAAALISGLASMLLHGVKKLPSRYIWMLLYSLIMFLFCFIVQPGVSAVFIVSLAIVLSLFGALAYKFAAGSYKQVSKTRKIGAMACLSLITIAIGAGSFWLIRAGDDAAPDITLKQLKTSTRYEDSTMNNPAEQGTYPVQSLLYGSPDNYRTEFNQSGSLTTQTVDASRFVEKWSSLRTKSLGFGPEAMPLNGRVWYPEGEGTFPLVLIVHGNHLMNDYSDPGYEYLGRLLASKGYIFVSVDENFLNFSPYEDLFLISPLLSENPARGLLLLEHLQTWKDWNSDPDNPFYQKVDMERIALIGHSRGGEAVAIAAAYNKLGRHPDHGDIKFDYNFSIRSLISIAGTDGQYKPQGKPLPLQDVNYLSLHGAHDMDVNSLDGAKQYHRIRYTKGTNYMKSLVYIYGANHGQFNGGWGRGDGAGLGNQLFNLRQIMPRDEQETIAKVFISSFLDATLKDQRQYREVFKDLGYAKEWIPDNLYVGNYYDSQTTLIADFHEDIDLQSTTLPGGSLRGENLQQWKEEKVKTKWGEADYSAVRLGWNSNGSSEPASYTVTLPDNGVETGRDSSIVFSLADARKTEESGDPKELINFTITVEDRKGHQASLPLSHISKLPPVIEGKLLKWPFSNAGNTSEPVFQSYDFQLDDYYKMNPDFNPQQLSKIRIEFNLTKRGSILLRDVGIRS	21.01	gnl|BL_ORD_ID|2229|hsp_num:0	2521			699	753	bacitracin
BGC0001382.1|Svaricin_24 # 27637 # 28875 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.711	BGC0001382.1|Svaricin_24 	27637	28875	+	Loose	2000	29.6462	adeJ	30.61	3000781	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCCCGCCGTCTGTTCACGTCCGAGTCCGTCACCGAGGGACACCCCGACAAGATCGCCGACCAGATCAGCGACACGATCCTCGACGCCCTGCTGCGCGGGGACCCCACGTCCCGCGTCGCCGTCGAGACCCTGATCACCACCGGTCTCGTCCACGTGGCCGGGGAGGTCACCACCACCGCGTACGCGCCGATCGCCCAGCTGGTCCGCGACAAGGTCCTGGAGATCGGCTACGACTCGTCCGCCAAGGGTTTCGACGGAGCCTCGTGCGGTATCGAGGTGTCCATCGGAGCGCAGTCGCCCGACATCGCCCAGGGCGTCGACAGTGCCTACGAACAACGGGTCGAGGGGGCCCCGGGCGGGGCCGCCGACGAGCTCGACCGGCAGGGCGCCGGCGACCAGGGGCTGATGTTCGGCTACGCCTGCGACGAGACGCCCACGCTGATGCCGCTGCCCCTGGAGCTCGCCCACCGGCTCGCGCGCCGGCTCACCGAGGTCCGCAAGGACGGCACGATCCCCTATCTGCGTCCGGACGGGAAGACCCAGGTCACCATCGAGTACCTGGGAAGCCGCCCGCAGCGGCTGGACACCCTGGTCGTCTCCACGCAGCACGCCGCGGACATCGACCTCGACACCCTGCTGACCCCGGACGTCCGGGAGTTCGTCGTGGAGCCGGTCCTCGCCGCCCTCCACGAGGACGGCATCAAGCTGGACACCGAGGGCTACCGGCTGCTGGTCAACCCGACCGGGCGTTTCGAGATCGGCGGCCCGATGGGCGACGCCGGCCTCACCGGCCGCAAGATCATCATCGACACCTACGGGGGCATGGCCCGCCACGGTGGCGGCGCGTTCTCCGGCAAGGACCCGTCCAAGGTGGACCGCTCGGCCGCCTACGCGATGCGCTGGGTCGCCAAGAACGTCGTCGCGGCGGGTCTCGCCTCCCGCTGCGAGGTGCAGGTCGCGTACGCGATCGGCAAGGCCGAGCCCGTCGGGCTGTTCGTCGAGACCTTCGGCACCGCCCGCCATCCGCAGACGGCCATCGAGCGGGCCATCTCCGAGGTCTTCGACCTGCGCCCGGCCGCGATCATCCGCGACCTCGACCTGCTCCGCCCGATCTACGCCCAGACCGCGGCCTACGGTCACTTCGGCCGCGAACTGCCCGACTTCACCTGGGAGCGCACCGACCGCGTCGAGGCCCTGAAGGCGGCCGTCGCATCGAAGGGCGGCGACGCGCGGTGA	MSRRLFTSESVTEGHPDKIADQISDTILDALLRGDPTSRVAVETLITTGLVHVAGEVTTTAYAPIAQLVRDKVLEIGYDSSAKGFDGASCGIEVSIGAQSPDIAQGVDSAYEQRVEGAPGGAADELDRQGAGDQGLMFGYACDETPTLMPLPLELAHRLARRLTEVRKDGTIPYLRPDGKTQVTIEYLGSRPQRLDTLVVSTQHAADIDLDTLLTPDVREFVVEPVLAALHEDGIKLDTEGYRLLVNPTGRFEIGGPMGDAGLTGRKIIIDTYGGMARHGGGAFSGKDPSKVDRSAAYAMRWVAKNVVAAGLASRCEVQVAYAIGKAEPVGLFVETFGTARHPQTAIERAISEVFDLRPAAIIRDLDLLRPIYAQTAAYGHFGRELPDFTWERTDRVEALKAAVASKGGDAR	MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENTVTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPEDVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLLQTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANALDTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQNWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVLSLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGKIFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFFMNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIKDASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPNGQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGSRMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGDAMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESWSIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEFAKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLGGVLSATFLGIFFIPVFYVWIRSMFKYKPKTINTQEHKS	38.94	gnl|BL_ORD_ID|574|hsp_num:0	630			828	975	tetracycline; rifampin; imipenem; trimethoprim; chloramphenicol; ticarcillin
BGC0001382.1|Svaricin_26 # 29752 # 30822 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.724	BGC0001382.1|Svaricin_26 	29752	30822	+	Loose	250	26.5646	vanG	25.0	3002909	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGTCCTCTCAGGACACCGCTGACACCGTTCTTCCCGAGGACGGGCCGGACGGGGGCGCCGGCGCCGACCTGCGCATCGCCGTCACCGGCTCCATCGCCACGGACCATCTCACCACCTTTCCCGGCCTGTTCGCGGACCAGCTGATCGCCGATCGACTGGACAAGGTGTCGCTCTCGTTCCTCGTGGACGACTTGGAGGTCCGCCGCGGAGGGGTGGCGGCGAACATCGCCTTCGGCATGGGCTGCCTCGGCCTCCGCCCGATCCTCGTCGGGGCGGTCGGAGCCGACTTCGCCGAGTACCGCGTGTGGCTGAAGGAGCACGGGGTCGACACCGAGTCCGTCCACGTCTCCGCCGAGCGCCAGACGGCTCGCTTCATGTGCATGACGGACCAGGCGCAGAACCAGATCGCCTCCTTCTACACGGGTGCCATGGAAGAGGCGGCCGGCATCGACCTGCACCCCGTCGCCGAGCGGTCGGGCGGGATCGATCTCGTGCTGGTCTCGCCGAACGATCCCCGGGCCATGCTCCGGCACACCGCCCAGTGCCGCGAGCTGGGCCTCCCGTTCGCCGCCGACCCCTCGCAGCAGCTGCCGCGACTGCGCCGCGACGACGTGCGCGACCTGGTCGACGGCGCCCGCTGGCTGTTCACCAACGAGTACGAGGCGTCTCTCCTGCTGGAACTCACGGGATGGCGGCACCGGGACGTCCTCGCCCGCGTGGGCCTCTGGGTCGTCACCCGTGCGGAGGCGGGCGTCACGCTCCACCGTGACGGCGACGCCCCCGTCACCGTCCCTGCCGTACAGGCCGGGCCGATCGCGGATCCGACCGGCGTGGGCGACGCCTTCCGGGCGGGTTTCCTCGCCGCCGCCGGCCGCGGTCTTGAGCCGGACGAGGCCGCCCGGTTCGGGTGCGCGATGGCCGTGCTCGCCCTGGAGAGCGTCGGTCCGCAGGAGTACACCGTCGCGCGAAGCGCACTCCTGCCCCGGATCGAGGCCGCGTACGGGCCGGTCACCGCGCAGGCGGTGGATGCGAGCGGGCTGCTCGGCCCCGGGAAGCGTCGACCGGGCTGA	MSSQDTADTVLPEDGPDGGAGADLRIAVTGSIATDHLTTFPGLFADQLIADRLDKVSLSFLVDDLEVRRGGVAANIAFGMGCLGLRPILVGAVGADFAEYRVWLKEHGVDTESVHVSAERQTARFMCMTDQAQNQIASFYTGAMEEAAGIDLHPVAERSGGIDLVLVSPNDPRAMLRHTAQCRELGLPFAADPSQQLPRLRRDDVRDLVDGARWLFTNEYEASLLLELTGWRHRDVLARVGLWVVTRAEAGVTLHRDGDAPVTVPAVQAGPIADPTGVGDAFRAGFLAAAGRGLEPDEAARFGCAMAVLALESVGPQEYTVARSALLPRIEAAYGPVTAQAVDASGLLGPGKRRPG	MQNKKIAVIFGGNSTEYEVSLQSASAVFENINTNKFDIIPIGITRSGEWYHYTGEKEKILNNTWFEDSKNLCPVVVSQNRSVKGFLEIASDKYRIIKVDLVFPVLHGKNGEDGTLQGIFELAGIPVVGCDTLSSALCMDKDRAHKLVSLAGISVPKSVTFKRFNEEAAMKEIEANLTYPLFIKPVRAGSSFGITKVIEKQELDAAIELAFEHDTEVIVEETINGFEVGCAVLGIDELIVGRVDEIELSSGFFDYTEKYTLKSSKIYMPARIDAEAEKRIQEAAVTIYKALGCSGFSRVDMFYTPSGEIVFNEVNTIPGFTSHSRYPNMMKGIGLSFSQMLDKLIGLYVE	102.01	gnl|BL_ORD_ID|1069|hsp_num:0	1157			837	1029	vancomycin
BGC0001382.1|Svaricin_27 # 30926 # 31237 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.718	BGC0001382.1|Svaricin_27 	30926	31237	+	Loose	2200	24.2534	Bifidobacterium bifidum ileS conferring resistance to mupirocin	36.11	3003730	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGCGGCAGTTGATCAGTTCAATAATCGGCGGCGCAGTGTTCATGGCGGTCTCCGCGGCCGGAGCAGGGCACGCGGCGGCGACCGAAGGAGGCGAGCCCGCGCCCGAGTGCGTCCGGTACGCGGCGAGCTGGCGCTACACCCACGTCACCAACGACTGCGGCACCGCGCACCGGGTGACGGTGGAGTACACCGACGGTGCGGAAGTGCCCTGCCGCGAGACGCAGCCGGGGGCGACGGTCACCTTCCCCGGGTACGGCACCGGCGGCAACGGCGTTCTGCGCGTGCTGCTCTGCCCGCCGCAGCCCGTCTGA	MRQLISSIIGGAVFMAVSAAGAGHAAATEGGEPAPECVRYAASWRYTHVTNDCGTAHRVTVEYTDGAEVPCRETQPGATVTFPGYGTGGNGVLRVLLCPPQPV	MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA	9.30	gnl|BL_ORD_ID|4694|hsp_num:0	2278			909	1017	mupirocin
BGC0001382.1|Svaricin_28 # 31326 # 31934 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.739	BGC0001382.1|Svaricin_28 	31326	31934	+	Loose	900	26.9498	lsaD	25.4	3005121	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	lsa-type ABC-F protein	ATGGACACACGATTCCGCGAGGGCGAGGTCATCGTCCGCCGGGAGATGCTGGACGGCCGCGAATGGCTGGTCTACCCCGTGCGGGTGGCCGGTGACGACGAGCACGCGCTCGCCGTGTACCTGGCCCAGGGCACGCCGCTCACCTTCGGCCGCGGCGACTTCCGCTGGGGCCCGCACGCCTGGCTCGAGTTCGCGCACGTGTGGCAGTCGAGCGGGGTGCTCCAGCTCCAGCGCCCCGGCGAGGGCTACGCGGTGTGGGGCCGCCGGGAGAGCGGCGAACTGCGCGAGTGGTACGTCAACTTCCAGGCCCCGTACGCCCGTACGGAGCGCGGGTTCGACACCCTCGACCACGAACTGGACCTCGTCATCCCCGGCGACGGCTCCCCGTACCGGTGGAAGGACGTCGAGCACTTCGAGGAACGGGTGCGCACGGGCGGCTTCACGAGCCGGGAGGCTGCCGCCGTGCGGGCGGCCGCTGCCCGGGTCGCCGATCTCGTCGAACGCGGCGAGTGCTGGTGGGAGCGGTGGCGGGAGTGGACCCCGCCCGCCGGGTGGGACGTTCCCGGCGCCGTCGCCCTGACGGACGGCGGCGCTCCGGCCGCTCGCTGA	MDTRFREGEVIVRREMLDGREWLVYPVRVAGDDEHALAVYLAQGTPLTFGRGDFRWGPHAWLEFAHVWQSSGVLQLQRPGEGYAVWGRRESGELREWYVNFQAPYARTERGFDTLDHELDLVIPGDGSPYRWKDVEHFEERVRTGGFTSREAAAVRAAAARVADLVERGECWWERWREWTPPAGWDVPGAVALTDGGAPAAR	MSNIKINNLTFGYTDQLIFDNVNINIDDQWKLGLVGRNGRGKTTLLKILLGEVDVHLEIKTNKSFVYFPQTINDKDQLTLFVLQELADFEQWELERELTLMGVDLDTLWRPFNSLSGGEQTKTLLALLFLDEHNYPLIDEPTNHLDKASREKVAAYLSEKKGYILISHDRNFLNKTTDHTLAIERADLQVYAGNFAIYEEEKRLRDLTEKAQDDKLRKEIGRLKQTAREKEAWSRNLEATKSRKKRGFDSETKRVDKGFIGRKAANMMQKSKNLEKRMKEDIADKELLLKNWEEVPGLEMSVLESHQKRLLTVENLAAGFEDFLFEPVSFTLEQGQVLALTGENGRGKSSLMKVLTGEFTGRYVGTFELAHNLVISEVRQLADNRGFLNEFAKKENLELELFLNNLRKLGVERKVFEQKIENMSQGQQRKVELARALSQPAHIYLWDEPLNYLDVFNQEQIIQMIKRSKPSMLVIEHDQYFVDQVADAQIELIKSSV	40.64	gnl|BL_ORD_ID|4773|hsp_num:0	3847			648	837	lincomycin; clindamycin; virginiamycin M1; tiamulin
BGC0001382.1|Svaricin_29 # 31941 # 33452 # -1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.763	BGC0001382.1|Svaricin_29 	31941	33452	-	Loose	400	26.5646	ErmN	27.93	3000592	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCTGCCGCCCCGGGATGCCGGGCGCAACGCGAGGCCGGAACGCCCCCGGTTCCGGGCCTCCGGTCGCGTACCGATACACATGGGGTCGACCAATCGAGCCGATCCGGGCCGTACGACCGAACCGTGGCCGTACAACCGGTTCGGCGGCACGACCGGGGACGCGGGGGCGGATCAGGTGGTACGTACAGCCGGTGCAGCGGGGCCCACGGGCCGGGAGCGGGGCGAACGGAAGCGGCACGAGACCCCGGGGGCACGGGGCGGGCCCGGGGAACGGGCGGGCCGGGGAGAACAGCGGGCCCCCGGCGAACGGGGAGACCGGCTGACGAGCGTGGACGCCGCCCGCGCCGTGGCGGTCTTCGCGATGTTCGCGGCACACATCGGCCCGCCGGCGAGGCCCGAGGGGGCGGGCCATCTGCTGGTCGCCCTCGACGGGCGCGCGCCCGCGGTCTTCACGCTGATCGCGGGGCTGTCGCTGTCGCTGTCCCGGGGCGGAACCCGCCCGCGCCCCGCGGCGAGGGGCGCCCGGCGCGGCACGCTGGTCCGCTGTGCCGTCCTCGCGGCGCTGGGCCTGGCTCTCGCGGAACTCAGGTCCGGGATCGCGGTCATCCTGGCCTTCTTCGCGGTGTACTTCCTGGCCGCCGAGCCACTCGCCCGGCTGCGGACGCGCAGTCTGCTCGTCGCGGCGGCGGTGTCGCCGGTGCTCGGGCCCGTGCTGTCGTACGTGCTGGGGCCGTACTTCGGCCACCGCGTGTCCGGCCGCGGCCGCTATCCGGGGTTCGACGCGGTCACGAGCTGGCCGGGGCTCCGCGACGCGCTGGACACCCTGCTGCTGTCCGGCGCGTACCCGTGGCTCACCTACTTCCCGTATGTGGTGGTGGGCATGGCGCTGGGCCGCGTGGTGGATCTGCGCAGGCCGGGCACGGCGGTCCGGCTCATCGGCTGGGGAGCCCTGGCCGCGCTGGCCGGCCACGGGCTGTCGGCGCTCGCGCTGGGGCCGGGCGGCGGGCGCGAAATGTTGCTGAGGGCCGTCGCCGACAGCCATCCGCTCGCGCTGAACGCCCCCGATCCGGTGCAGGCGGTTCTCGCCGCCCAGGCGGGCGCGATACCGAGCACCTCCTGGGCCTGGCTGCTGGTCGACGGACCGTACAGCCAGACGCCTTTCGAGACCGTCGCCAACATCGGCGCGGGTGTGCTGCTCCTGGGCCTCGCCGTCGCGGCCGGATGCAGCGGGCCGCTCCGGCCCCTGCTGCGGCCCCTGGCCACCGTCGGCACGATGGGGCTCTCGGTGTACGCCGTCCACGTCCTGGCCCGTGCCGAGTTGCGGCCCCAGCACGGCTGGGTGGCGCTGGGCGCGTTCTGCCTGGTCTCCCTGGCGGCCTGCGCACTGTGGGCGCGCGTCCTCCGCGGCAGGGCGCTGGGGCGGGGGCCGCTGGAGTGGGCCCTGCACGTGCTGGTGCGGGCCGCGACGTCGAGGAGAGGCGCGTCGCACCCCGGCGGAACCGGGGCGTAG	MLPPRDAGRNARPERPRFRASGRVPIHMGSTNRADPGRTTEPWPYNRFGGTTGDAGADQVVRTAGAAGPTGRERGERKRHETPGARGGPGERAGRGEQRAPGERGDRLTSVDAARAVAVFAMFAAHIGPPARPEGAGHLLVALDGRAPAVFTLIAGLSLSLSRGGTRPRPAARGARRGTLVRCAVLAALGLALAELRSGIAVILAFFAVYFLAAEPLARLRTRSLLVAAAVSPVLGPVLSYVLGPYFGHRVSGRGRYPGFDAVTSWPGLRDALDTLLLSGAYPWLTYFPYVVVGMALGRVVDLRRPGTAVRLIGWGALAALAGHGLSALALGPGGGREMLLRAVADSHPLALNAPDPVQAVLAAQAGAIPSTSWAWLLVDGPYSQTPFETVANIGAGVLLLGLAVAAGCSGPLRPLLRPLATVGTMGLSVYAVHVLARAELRPQHGWVALGAFCLVSLAACALWARVLRGRALGRGPLEWALHVLVRAATSRRGASHPGGTGA	MPSRPRTDSPHRHEGPAGPARLDRDEARRVWGQNFFRSAGSARRFARQLTGAESAGNDSVTVEVGPGAGRITKELVRDGHPIVAVEVDPHWADRLAELELPNLTVVNDDFTTWPLPDGPLRFIGNLPFGTGTRMLRRCLALGPDRCREGVFLLQKQYTRKRTGAYGGNLFNAQWEPWYTFRRGLGFPRQEFAPVPGSDTETLLVRSRPRPLAPWSRHAAYQRFVEDVFNTSRLTIGEAARALDRRAGPGWLRGARVPPGLRVKDITAEQWADLFHACTPPPARRISPQRRR	172.85	gnl|BL_ORD_ID|232|hsp_num:0	260			105	426	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0001382.1|Svaricin_30 # 33818 # 34582 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.724	BGC0001382.1|Svaricin_30 	33818	34582	+	Loose	500	27.335	mphI	38.24	3003991	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGACGACTGGAACCGCGTTGCACTGGATCGACGGCACCTGGGTCGGTCCGGGAAGCCGTGACGGCACTGACGTCCGTCCGGCGCCGGGGGAGCAGAGGACTGACGGGACCGCGGGCGACGGTCGCGAGATGGCGGCACGGGCGGTCGCGGCGGCCCGGCGGGCCTTCGGCGAGACGCGCTGGAAGGACGACCGGCATCTGCGGGCCAGGACCCTGCACGAGATGGCGGACGTCTTCGCCGCGCACGTCGGGCAGTTGACCGAGGCGCTGGCCCAGACGGACGGAAGGCGCAGGCAGCACGCGCGCTTCGAGGCGGAGGCGGTGCCGTCGCGACTGCGCTACTTCGCCTCGCTCGTGCGCACCGAGCACGGCCGTGCCCTCGAAGCCGCCCCGGGGAAGTGTTCCCTGGTCCTGCGGCGCCCCCGAGGCGTGACGGGAATCGTCGTACCGCGCCGGTCCCCTGTGGTCGTGCTCATCTGCTCCCTGGCCCCGGCCCTGGCGGCCGGTACGACCAGTGTGGTGGGGATGCCGGAGCAGACGGCCCGCGTCAACTCCCTGGTCTTCGGGATCTTCTCCGAGATCGAGTCCCTGCCACGCGGCGTCGTGAACGGGTTCACGGAGGAGGACGGCGCGGGCGCCCGGTATCTGGTGGCCGCCGCGGACGTGCCGTGCGCCCTCGACGGCAGCTCCCGGGAAGCGTCGGCGATGGAGGACTTCGTCGAGTGCGAGCGCGTGACCATCACCCCCGGAACGATTCAGCGGTAG	MTTGTALHWIDGTWVGPGSRDGTDVRPAPGEQRTDGTAGDGREMAARAVAAARRAFGETRWKDDRHLRARTLHEMADVFAAHVGQLTEALAQTDGRRRQHARFEAEAVPSRLRYFASLVRTEHGRALEAAPGKCSLVLRRPRGVTGIVVPRRSPVVVLICSLAPALAAGTTSVVGMPEQTARVNSLVFGIFSEIESLPRGVVNGFTEEDGAGARYLVAAADVPCALDGSSREASAMEDFVECERVTITPGTIQR	MTIAKPNDDYTQVIQEMLEIAGKHGVNLIPEGIEMNESGMDFLVGFAEEAGTGARWILRKPRRPDVLDRADNEARVLKLIQSHLSVDVPDWRIYTPELIAYPLLSGQPAASVSMEGYAWNMDHENPGDGFIRSLAEALVALHGVDHDAARAAGLRVKSPQEVRDETARNMEDIKSRLGVSDALWERWQKWLEEDSYWPTHSALIHGDLHPPHILIDERVQVTGLLDWTESEVASPAKDFVLYYAIYGEHNLRVLLDRYEQAGGKVWPRMFDHIVEQHAAYPVLIAQFALLTGQEEYMTMARNALGLTE	82.47	gnl|BL_ORD_ID|2234|hsp_num:0	2527			132	234	erythromycin; telithromycin; tylosin
BGC0001382.1|Svaricin_8 # 10419 # 11234 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.725	BGC0001382.1|Svaricin_8 	10419	11234	+	Loose	450	122.479	Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan	32.44	3004045	protein variant model	G93A	n/a	disinfecting agents and antiseptics; isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant fabI	ATGGGACTGCTCAACGGAAAGACCCTGCTGGTCACGGGGGTCATCACCGACTCCTCGATCGCCTTCCACGCCGCCCGGGCGGCGCAGGAGCAGGGCGCACGCGTCGTCCTCACCGGCTACGGACGGCTCAGCCTCGTCCAGCGCATCGCCAGGCGGCTGCCCGAGCCCGCCCCGGTGATCGAGCTGGACGTGACCGACGCGGAACAACTGGCCTCGCTGGCCGACCGCGTGCGCCCGCACGCCGACCGGATCGACGGCGTGCTGCACTCGGTCGCCTTCGCCCCGCCCGGGGCGCTCGACGGCAACTTCCTCACCACGTCGTGGGACGAGGCCGCCACCACGTTCCGGATCTCCACCTACTCGCTCCAGGCGCTCACCAGCGCCGTGCTGCCCCTCATGGACCGCGGCGGATCGGTCGTCGGGCTCGATTTCGACGCGTCCTCCGCGTGGTCCGGCTACGACTGGATGGGTGTGGCGAAAGCCGGCCTCGAGTCGTGCACCCGCTATCTGGCGTCGCACCTCGGCGCACGCGGCATCCGGGTCAACCTCGTGGCGGCGGGGCCCCTGTTGACGATGGCCGCACGGAACATCTCGCCCACCGCCGAGTCCGAGGGCGCCGCGCCGTTCGGCTCGGAGTGGTCGGAGCGCTCACCCCTCGGCTGGGACCCGTCCGACTTCGAACCGGTCGCCCGCGCGTGCGTCGCGCTGCTCTCCGATCTCTTCCCGGCGACCACCGGCGAGATCGTGCACGTCGACGGCGGGGCGCACGCCATCGGGGATCGCCCTGCGCGCCTCGCGGCGGAGGTGGCGGGATGA	MGLLNGKTLLVTGVITDSSIAFHAARAAQEQGARVVLTGYGRLSLVQRIARRLPEPAPVIELDVTDAEQLASLADRVRPHADRIDGVLHSVAFAPPGALDGNFLTTSWDEAATTFRISTYSLQALTSAVLPLMDRGGSVVGLDFDASSAWSGYDWMGVAKAGLESCTRYLASHLGARGIRVNLVAAGPLLTMAARNISPTAESEGAAPFGSEWSERSPLGWDPSDFEPVARACVALLSDLFPATTGEIVHVDGGAHAIGDRPARLAAEVAG	MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK	103.44	gnl|BL_ORD_ID|4712|hsp_num:0	2666			0	750	triclosan
BGC0001382.1|Svaricin_9 # 11231 # 11698 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.718	BGC0001382.1|Svaricin_9 	11231	11698	+	Loose	500	25.0238	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid	46.43	3004157	protein variant model	E40Q	n/a	salicylic acid antibiotic	antibiotic target alteration	aminosalicylate resistant dihydrofolate synthase	ATGACGACGGCGGCAACCCGGTCCTTCACCACCGAGGAGCTCGCGTCGCTGCCGGCGGGGGAGCACCTCGGCCACAGCACCTGGCACGGCGTCCCCCAGAGCCGGATCGATCTGTTCGCCGAGGCCACCGGCGACCACCAGTGGATCCACACCGACCAGGCCGCCGCGGCCGAAGGCCCCTTCGGCGGCACGATCGCCCACGGCTTCCTCACGCTCTCCCTGCTGCCCCTGCTGACGTCCGAGGTGTACGACGTCACCGGTGTGTCGGCGGCCGTCAACCACCGTGTCGACAAGGTGCGTTTCCGATCCCCGGTCCCCGCGGGCGCCAGGGTGCGGGCCGGAGTCGACCTCGTCTCGGTGCGACCCCGCCCCCGCGGCTACACGGAGGTGACGGTGAAGGTCGCCATCGAGCTGGAGGACGGCGGAACCGCCTGCACCTGCGAGCAGACCACGCTCTACCGGGCCTGA	MTTAATRSFTTEELASLPAGEHLGHSTWHGVPQSRIDLFAEATGDHQWIHTDQAAAAEGPFGGTIAHGFLTLSLLPLLTSEVYDVTGVSAAVNHRVDKVRFRSPVPAGARVRAGVDLVSVRPRPRGYTEVTVKVAIELEDGGTACTCEQTTLYRA	MNSTNSGPPDSGSATGVVPTPDEIASLLQVEHLLDQRWPETRIDPSLTRISALMDLLGSPQRSYPSIHIAGTNGKTSVARMVDALVTALHRRTGRTTSPHLQSPVERISIDGKPISPAQYVATYREIEPLVALIDQQSQASAGKGGPAMSKFEVLTAMAFAAFADAPVDVAVVEVGMGGRWDATNVINAPVAVITPISIDHVDYLGADIAGIAGEKAGIITRAPDGSPDTVAVIGRQVPKVMEVLLAESVRADASVAREDSEFAVLRRQIAVGGQVLQLQGLGGVYSDIYLPLHGEHQAHNAVLALASVEAFFGAGAQRQLDGDAVRAGFAAVTSPGRLERMRSAPTVFIDAAHNPAGASALAQTLAHEFDFRFLVGVLSVLGDKDVDGILAALEPVFDSVVVTHNGSPRALDVEALALAAGERFGPDRVRTAENLRDAIDVATSLVDDAAADPDVAGDAFSRTGIVITGSVVTAGAARTLFGRDPQ	31.83	gnl|BL_ORD_ID|2414|hsp_num:0	2804			57	132	para-aminosalicylic acid
BGC0001382.1|Svaricin_25 # 28872 # 29774 # 1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=13bp;gc_cont=0.715	BGC0001382.1|Svaricin_25 	28872	29774	+	Loose	660	25.0238	MexS	32.56	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGCGCGCTCGGCGACCTCATCAGCGCCGACGAACCCACCTTCTCCTTCGAGTTCTTCCCCCCGAGGACCGAGGCCGGGCAGCGGTCGCTGCTCCGCGCGATCCGCCGCATCGAGGCCCTGACGCCGTCGTTCGTGTCGGTCACCTACGGAGCCGGCGGCTCCTCGCGCGACCGCACCGTCGAGGTGACGAAGCGCATCGCCGCCGAGACCACGCTGCGCCCGGTGGCCCATCTGACCGCCGTCGGCCACTCGGTGGCGGAACTGCGGCACATCATCGGCCAGTACGCGGACGCCGGCATCCGGGACGTGCTGGTGCTCCGCGGGGACCCGCCCGGCAGCCCGCGCGGGCCGTGGACGCCGCACCCGCAGGGCTTCGACTACGCCCATCAACTGGTCTCCCTGGTCAGGGGGCTGGGGGACTTCAGCGTCGGCGTCGCGGCCTTTCCCGAGTGCCACCCGCGCTCTCCCGACCGGGACAGCGACATCCGCCACTTCGTCGCCAAGTGCCGGGCCGGGGCCGACTACGCCATCACCCAGATGTTCTTCCACGTGGAGGACTATCTGCGGTTCCGCGACCGGGTCGAGGCCGCCGGCTGCGAGACCCCGATCATTCCGGGGATCATGCCGGCCACGGACGTGCGCCAGATCCGACGGTTCTCCGAGCTGAGCGACGCCGCGTTCCCGGAGGACCTCGCGCACCGGCTGGAGGCCGCCCGCCAGGACCCCGGCACCGCCCACCGCATCGGCGTCGAGTACGCCACCGGCATGGCGCTGCGGCTCCTCGCGGAAGGCGCTCCGGGGCTGCACTACATCACCCTCAACCGCTCCGACGCCGCAGCCGACATCCACCGCAACGTCATGAGTGCAAGGAGTTCCGATGTCCTCTCAGGACACCGCTGA	VSALGDLISADEPTFSFEFFPPRTEAGQRSLLRAIRRIEALTPSFVSVTYGAGGSSRDRTVEVTKRIAAETTLRPVAHLTAVGHSVAELRHIIGQYADAGIRDVLVLRGDPPGSPRGPWTPHPQGFDYAHQLVSLVRGLGDFSVGVAAFPECHPRSPDRDSDIRHFVAKCRAGADYAITQMFFHVEDYLRFRDRVEAAGCETPIIPGIMPATDVRQIRRFSELSDAAFPEDLAHRLEAARQDPGTAHRIGVEYATGMALRLLAEGAPGLHYITLNRSDAAADIHRNVMSARSSDVLSGHR	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	88.50	gnl|BL_ORD_ID|1039|hsp_num:0	1041			153	282	ciprofloxacin; trimethoprim; chloramphenicol
